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Abstract
Proteins have been optimized by evolution for billions of years to work on a
nanometer scale. Therefore, they are extremely promising for nanotechnological
applications. Cytoskeletal filaments propelled by surface-attached motor proteins
have been recently established as versatile transport platforms for nano-sized cargo
in molecular sorting and nano-assembly devices. However, in this gliding motility
setup, cargo and motors share the filament lattice as a common substrate for their
activity. Therefore, it is important to understand the influence of cargo-loading
on transport properties.
By performing single molecule stepping assays on biotinylated microtubules, it
was shown that kinesin-1 motors first stop and then detach when they encounter
a streptavidin obstacle on their path along the microtubule. Consequently, the
deceleration of streptavidin coated microtubules in gliding assays could be at-
tributed to an obstruction of kinesin-1’s path on the microtubule rather than to
”frictional” streptavidin-surface interactions.
The insights gained by studying kinesin’s behavior at obstacles were then
used to demonstrate a novel sensing application: Using a mixture of two distinct
microtubule populations that each bind a different kind of protein, the presence
of these proteins was detected via speed changes in the respective microtubule
populations. In future applications, this detection scheme could be combined with
other recent advancements in the field, creating highly integrated lab-on-a-chip
devices that use microtubule based transport to detect, sort and concentrate
analytes.
It has been envisioned that the kinesin-1-microtubule system could be used
for even more complex appliances like nano-assembly lines. However, currently
available control mechanisms for kinesin-1 based transport are not precise enough.
Therefore, improved temporal control mechanisms for kinesin-1 were investigated:
Using a polymer that changes its size in solution with temperature, starting and
stopping of gliding microtubules was demonstrated. In combination with local
heating by light, this effect could be used to control the gliding of single micro-
tubules. Finally, a strategy to create photo-switchable kinesin-1 was developed
and tested for feasibility using molecular modeling.
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1
Introduction
In 1959 Feynman introduced the idea of manipulating matter on the atomic scale in
his visionary talk ”There’s Plenty of Room at the Bottom”. Now, fifty years later,
this concept which was later termed ”nanotechnology” is much more concrete.
In the recent past, miniaturization has been one of the main factors driving
technological advances. Information technology is the most obvious example, where
continuing miniaturization has achieved an exponential growth in processing speed
and data storage capacity (Moore’s law1). Using more and more sophisticated
photo-lithography technologies, it has become possible to manufacture structures
with sizes of a few tens of nanometers in mass production. Under laboratory
conditions, scanning probe microscopy even allows the manipulation of single
atoms2–4. In addition to these static nano-structures, some active devices like
nanocars and nanoelevators have been demonstrated5,6. However, we are still
far from the ultimate goal of molecular manufacturing. The idea of molecular
manufacturing is to use self-replicating nano-machines working highly parallel to
produce nanoscopic as well as macroscopic devices with atomic precision7,8. A
major hurdle on the way towards this goal is that principles like inertia, friction,
energy storage, and force generation work completely different on the nanometer
scale9. Therefore, it is impossible to simply down-scale macroscopic machines
to generate nano-factories. Nevertheless, as is often the case, nature provides us
with a host of examples that we can learn from, use and copy. Proteins have
been optimized by evolution for billions of years to work on a nanometer scale.
They are adapted to the physical principles of the nano-world. The better we
1
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understand the mechanisms of proteins, the more we learn that they work like
tiny machines that self-organize to perform complex and specific tasks. Especially
recent advances in single molecule techniques have led to an unprecedented level
of understanding of the mechanochemical mechanisms governing the function of
proteins. In particular, motor proteins and cytoskeletal filaments, responsible
for intracellular transport and organization have been studied in great detail.
The most well understood biomolecular transport system, consists of the motor
protein kinesin-1 and cytoskeletal filaments called microtubules. These proteins
are now commonly studied in synthetic environments10–15. In addition to helping
to understand kinesin-1’s mechanochemical cycle, these so-called ”in vitro motility
assays” have shown great potential as components of devices engineered at the
micro- and nanoscale level16–18.
Aim: The aim of this thesis is to promote the use of the motor protein kinesin-1
in nanotechnological applications by:
• Improving the understanding of the behavior of kinesin-1 at obstacles on
the microtubule lattice. This comprehension is crucial for efficient transport
of microtubules that are packed with cargo.
• Demonstrating that tasks such as detection and sorting can be realized in
the near future using the kinesin-1-microtubule system for transport and
biomolecular recognition for analyte binding.
• Investigating next-generation methods of precise spatio-temporal control of
kinesin-1. Such control mechanisms are necessary to allow more complex
appliances such as nano-assembly lines where kinesin-1 motors could serve
as nano-conveyors.
Summary: To pursue these goals, minimalistic in vitro motility assays were
extended by molecules serving as roadblocks. Single molecule assays showed that
kinesin-1 motors briefly stop and then detach when encountering an obstacle
on the microtubule lattice. To test whether this also affects cargo transported
by multiple motors, microtubules propelled by many surface-attached kinesin-1
2
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molecules were studied. In these ”gliding assays”, the speed of microtubules
was reduced in correlation with the obstacle density on their lattice. Based on
the insights gained in these experiments, a novel sensing application was demon-
strated: Microtubules labeled either with biotin or rhodamine were mixed. Adding
streptavidin (i.e. a protein that specifically binds biotin) did then selectively slow
down the biotinylated microtubules, while anti-rhodamine antibodies slowed the
rhodamine-labeled filaments. In addition, it was shown that versatile detection via
antigen-binding fragments of antibodies or via aptamers (i.e. oligonucleotides that
specifically bind an analyte) is possible. These results could be combined with
other recent advancements in the field, creating highly integrated lab-on-a-chip
devices that use microtubule based transport to detect, sort19 and concentrate20
analytes.
It has been envisioned that the kinesin-1-microtubule system could be used
for even more complex appliances like nano-assembly lines. However, currently
available control mechanisms for kinesin-1 based transport21–29 are not precise
enough for such appliances. Therefore, improved temporal control mechanisms for
kinesin-1 were investigated: Using a polymer that changes its size in solution with
temperature, starting and stopping of gliding microtubules was demonstrated. In
combination with local heating by light30, this effect could be used to control
the gliding of single microtubules. Finally, a strategy to create photo-switchable
kinesin-1 was developed based on an approach that was successful in creating
a photo-switchable glutamate channel31. The feasibility of this strategy was
confirmed by initial experiments and molecular modeling.
As background information, the following sections will give an overview of
the proteins involved in biomolecular transport and biomolecular recognition.
Finally, the last section in this chapter will introduce, how these proteins can be
implemented for nanotechnological applications.
1.1 Biomolecular transport in vivo
As a first step towards the domestication of biomolecular motors for nanotechno-
logical applications, their behavior within their native habitat — the cell — needs
to be considered. Short range transport of biomolecules within cells is usually
3
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Figure 1.1: Fluores-
cence image of fila-
ments of the cytoskele-
ton - In these mouse fi-
broblast cells, actin (pur-
ple), microtubules (yellow),
and nuclei (green) are la-
beled by immunofluores-
cence. The scale-bar in
the upper-right corner cor-
responds to a distance of
15 µm. Courtesy of the Na-
tional Institute of General
Medical Sciences32
very efficiently handled by diffusion. However, diffusion becomes inefficient for
long range transport. For example, to diffuse to the end of a one meter long
axon, an average protein needs approximately 2000 years. Additionally, the force
that can be exerted by diffusion is limited by the thermal energy of the system33.
Therefore, long range transport, and force creation within cells is performed by
motor proteins. In order to be able to produce force, these motors need to operate
on relatively rigid substrates and are therefore usually associated with filaments of
the cytoskeleton. The cytoskeleton (see figure 1.1), together with motor proteins
is responsible for a wide range of cellular functions. The most prominent examples
are: cell-shape, cell-motility, mechanical stability, organelle positioning, intracel-
lular transport and cell-division. The main proteins involved in these processes
are: actin filaments, the actin-based myosin motor family, intermediate filaments,
microtubules and the microtubule-based dynein and kinesin motor families. This
work focuses on microtubules and kinesin-1 motors. Therefore, only these proteins
will be described in more detail in the following.
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Microtubules
Being the most rigid cytoskeletal filament, microtubules give shape to cellular
protrusions such as axons, dendrites and cilia. Therefore, they were long thought
to be the ”bones” of the cell. However, this view is quite misleading. In most cells,
microtubules are highly dynamic structures that constantly undergo growth and
α-tubulin
β-tubulin
Figure 1.2: Structure of a tubulin het-
erodimer - The protein backbone of α-
(blue) and β-tubulin (green) with the re-
spective GTP molecules (red). PDB id:
1TUB34.
shrinkage10,35. They self-organize
into a star-like fashion protruding
outward from a point near the nu-
cleus, called the microtubule organiz-
ing center36–38 (see figure 1.1). This
organization provides a coordinate
system for the cell to direct intracel-
lular transport and correctly position
its organelles39. During mitosis, mi-
crotubules are drastically rearranged
to form the mitotic spindle which is
paramount for the alignment and cor-
rect separation of chromosomes40,41.
To be able to perform such a
wide variety of tasks, microtubules
must be both mechanically stable and
quickly rearranged. Mechanical sta-
bility is achieved by a characteristic
structure: Microtubules self-assemble
from α- and β-tubulin heterodimers
with a combined molecular weight of
≈ 110 kDa (dimer structure shown
in figure 1.2). These dimers are ar-
ranged in protofilaments within the microtubule lattice (figure 1.3A). Usually,
thirteen of these protofilaments are associated laterally to form hollow tubes of
25 nm diameter (figure 1.3B). The amazing versatility of microtubules is achieved
by switching between growing and shrinking phases42. This switching process,
5
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called ”dynamic instability” is driven by GTP hydrolysis: In solution, most
tubulin dimers are loaded with two molecules of GTP (”GTP-tubulin”). One of
these molecules is bound to α-tubulin at the interface of the α- and β-subunit of
the dimer (see figure 1.2) and is never hydrolyzed. The other GTP molecule is
bound to β-tubulin at the interface of two dimers within a protofilament. This
second GTP molecule is hydrolyzed soon after assembly, converting GTP-tubulin
to ”GDP-tubulin”43. Therefore, growing microtubules consist mainly of GDP-
tubulin, with a small cap of GTP-tubulin at the growing end (figure 1.3C-1). This
GTP-cap is thought to stabilize growing microtubules depending on its length and
its structure11,44,45. However, when GTP hydrolysis catches up with the tip of the
microtubule, the filaments containing GDP-tubulin at their tip become metastable
(figure 1.3C-2) and usually undergo rapid shrinkage called ”catastrophe”42 (figure
1.3C-3). This process releases tubulin dimers loaded with GDP into solution,
where the nucleotide is exchanged for GTP (figure 1.3C-4). From the shrinking
phase, microtubules can be ”rescued” back into the growing phase. A recent study
suggests, that these rescues are facilitated by remnants of GTP-tubulin within
the microtubule lattice46, rather than by the addition of fresh GTP-tubulin to
the shrinking microtubule-end. Dynamic instability can be reproduced in vitro
with purified tubulin and GTP in the right buffer conditions42, showing that it
is an intrinsic feature of tubulin. Microtubules that are grown in vitro are also
an integral part of in vitro motility assays, however in these assays, it is often
more desirable to have static microtubules which can be achieved by growing
microtubules in the presence of the slowly hydrolyzable GTP analog Guanosine
5’-[α,β-methylene] triphosphate (GMPCPP) or using the microtubule stabilizing
drug taxol47.
In addition to their structural functions, microtubules provide a functional
scaffold for a whole class of microtubule associated proteins (MAPs). Some of these
proteins help to regulate microtubule dynamics by nucleating new microtubules49,50
and by promoting microtubule growth or depolymerization51. Other MAPs bind all
along the microtubule lattice, making it quite a crowded environment. For example,
Tau, MAP2 and MAP4 stabilize microtubules and control bundling and spacing of
microtubules in the axons and dendrites of neurons52,53. However, by far the best
studied and most intriguing (especially with respect to nanotechnology) group of
6
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A C
B
Figure 1.3: Overview of microtubule structure and dynamics - (A) Dimers
of α- and β- tubulin are organized as protofilaments within the microtubule lattice.
(B) Microtubules are made up of thirteen protofilaments that form hollow tubes
with a diameter of 25 nm. Due to the asymmetric structure of the tubulin dimers
microtubules are polar. The end that is capped by α-tubulin is called the minus-end,
the other one is called plus-end (capped by β-tubulin). (C) Microtubule dynamics.
(1) Tubulin dimers loaded with GTP polymerize preferentially at the plus-ends
of microtubules. Once assembled, the dimers hydrolyze GTP to GDP. (2) If the
stabilizing cap of GTP tubulin is lost, microtubules become metastable and rapidly
start to shrink (3). When tubulin dimers are in solution, GDP is quickly exchanged
for GTP (4) and can be added to the growing ends of microtubules again. Adapted
from Akhmanova and Steinmetz 48 .
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proteins that associates with microtubules are the motors of the dynein- and kinesin
families. These motor proteins move along the lattice of microtubules, transporting
cargo (e.g. vesicles containing neurotransmitters), positioning organelles and
helping to rearrange the microtubule network.
Kinesin-1
Motor
domains
Neck-linker
Amino-terminus
Carboxyl-terminus
Globular tail
Stalk
Dimerization-domain
Coiled-coil
tail
Heads
• ATP hydrolysis
• Microtubule binding
Tail
• Cargo binding
• Regulation
Figure 1.4: Structure of a kinesin-1 heavy chain dimer - The heads are
available as crystal structures, the structures of stalk and tail are inferred from
electron microscopy and coiled-coil prediction analyses. Adapted from Woehlke and
Schliwa 54 .
Kinesin-1 (formerly called ”conventional kinesin”) is the founding member of
the kinesin family of motor proteins. It was first discovered in the giant axon of the
squid, where it transports vesicles from the cell body to the synapse55. Kinesin-1
is a heterotetramer of two heavy (≈ 120 kDa each) and two light chains (≈ 60 kDa
each). The light chains are thought to have regulatory functions and facilitate
cargo binding56–58. They are not required for movement along microtubules. The
heavy chains form homodimers (figure 1.4), consisting of two N-terminal motor
domains (also called ”heads”) which are connected via a short ”neck linker” to
an elongated coiled-coil domain called ”stalk”. The C-terminal region consists
of two globular domains which function as cargo binding domains. If not bound
to cargo, this ”tail” folds back and inhibits the motor domain, so that the full-
8
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Figure 1.5: Current model of the
kinesin-1 stepping mechanism - (a)
One head is nucleotide-free (Ø), the other
head contains ADP (D). (b) ATP binding
to the attached head results in neck-linker
docking, inducing internal strain between
the two heads. (c) The strain causes the
weakly bound rear head to detach. The
detached head performs biased diffusional
search for the next forward binding site.
Once the diffusing head binds to the for-
ward binding site (d), ADP is rapidly re-
leased, and the previously weakly bound
head strongly binds to the microtubule
(e). After hydrolysis of ATP and the re-
lease of phosphate by the now rear (yellow)
head, the cycle can begin anew. (T) indi-
cates either the ATP- or the ADP · Pi state.
Adapted from Kawaguchi 62 with new in-
formation fromYildiz et al. 63 .
Pi
ATP
a +-
b +-
c +-
d
e
biased
diffusional
search
+-
internal
strain
D
D
D
D
Ø
D
T
T
T
ADP
+- ØT
length motor alone does not move along microtubules, avoiding unnecessary ATP
consumption59–61.
Kinesin-1 moves in a stepwise hand-over-hand mechanism comparable to our
own walk12,62,64. Its motor-domains hydrolyze ATP, moving the molecule a step of
8.2 nm (the length of a tubulin dimer) towards the microtubule plus-end with each
hydrolysis cycle65,66. During ATP-hydrolysis, the heads cycle through different
nucleotide-states with distinct affinities for the microtubule: The nucleotide-free-,
the ATP- and the ADP · Pi-states are tightly bound, while the ADP-state is
loosely bound to the microtubule67–72. It has been shown that kinesin-1 can take
approximately 100 steps before dissociating from its track, allowing single motors
to transport cargo over long distances59,73. This remarkable processivity requires
that at least one head is bound to the microtubule at all times. To achieve this
unique feat, the two motor heads need to influence each other. They need to
9
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make sure that the ATP cycles of each motor head are out of phase and thus
rarely both in a weakly-bound state. How this so-called ”gating” is achieved has
not yet been clarified with certainty. However, in a recent study, Yildiz et al. 63
presented compelling evidence for a strain-gated release of the trailing head.
Figure 1.5 shows this strain gate in the context of a current model of the kinesin-1
stepping mechanism62. In solution, both heads contain ADP. Upon binding to
the microtubule, one head rapidly releases ADP74 (figure 1.5a). Binding of ATP
to this nucleotide free head then causes the neck linker to dock to the head in
a forward direction likely introducing internal strain into the molecule75 (figure
1.5b). Yildiz et al. showed that this internal strain can cause the trailing head
to detach and helps to avoid futile ATP cycles63. Afterwards, the trailing head
probably undergoes a diffusional search, which is biased towards the plus-end76,77
(figure 1.5c). Once this head reaches the forward binding site (figure 1.5d), ADP
is rapidly released74,78, causing the now leading head to assume a tightly bound
conformation (figure 1.5e). This 16 nm step of the head propels the center of mass
of the molecule forward by 8 nm. The cycle can begin anew when the rear head
releases Pi and is converted into a weakly bound ADP state.
During its stepping cycle, single kinesin-1 molecules can pull cargo against a
force of 6 pN79,80. This corresponds to an energy production of 49 pN · nm per
8.2 nm step. In the meantime, kinesin-1 hydrolyzes one ATP molecule66, which
releases 100 pN · nm of energy at cellular concentrations of ATP, ADP and Pi 9.
This means, that this motor protein has an energy efficiency of almost 50 %, which
is a lot better than the combustion engines used in a car (≈ 35 % efficiency).
These properties show that kinesin-1 is an extremely interesting molecular motor
that could inspire new nanotechnological applications.
1.2 Biomolecular recognition
One of the striking features of biomolecular systems is their ability to specifically
recognize their target molecules. For example, this allows enzymes to bind only to
their desired substrates, avoiding unwanted side-reactions. This high specificity is
also very desirable for nanotechnological applications, where the specific binding
of cargo is one of the basic requirements for efficient transport and molecular
10
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detection (see also section 1.3). Especially striking in this respect are antibodies
which allow highly specific and very strong binding to almost any kind of molecule,
including relatively small organic compounds like fluorescent dyes. Antibodies
are already the most important tool used for molecular detection in assays like
the western blot81 or the enzyme-linked immunosorbent assay (ELISA)82,83. The
following section will describe how antibodies are created in vivo and how this
can be exploited to create custom made antibodies against virtually any molecule.
Afterwards a relatively novel class of recognition molecules, the aptamers will be
introduced as an intriguing alternative to antibodies.
Antibodies
Antibodies (also called immunoglobulins) are proteins used by the immune system
to recognize and target substances not belonging to the organism (i.e. pathogens).
Several different classes of antibodies of different sizes and structures are known.
Only the most abundant and best studied class, immunoglobulin G (IgG), will
be discussed here. IgG antibodies consist of two identical light and heavy chains
that are arranged in a Y shape and reach a molecular weight of about 150 kDa
(figure 1.6A and B). The distal parts of the light and heavy chains are highly
variable and form the antigen binding domains (indicated by (*) in figure 1.6).
Each light chain is connected to one heavy chain by one disulfide bond and the
heavy chains are interconnected by two disulfide bonds (orange bars in figure
1.6B). The minimal parts required for antigen binding (fragment antigen binding,
FAB; figure 1.6C and D) can be cleaved off the constant domain of an antibody by
papain digestion. As shown in figure 1.6C and D, both the light- and the heavy
chain usually contribute to antigen (figure 1.6C and D red part) binding84.
Within an organism, antibodies are produced by cells of the immune sys-
tem called ”B-lymphocytes”. During differentiation, each B-lymphocyte clone
randomly selects one of ≈ 10 billion combinations of variable domains of anti-
bodies. This diversity is achieved by somatic recombination (also called V(D)J-
recombination) of variable-, diversity- (only for heavy chains), joining- and constant
gene segments87. A very good explanation of this process is given in an on line
flash animation by Campbell 88 . Once an antigen is detected by a B-lymphocyte,
11
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Figure 1.6: Composition of an immunoglobulin G and an antigen bind-
ing fragment - An IgG antibody consists of two heavy- (blue) and two light
chains(yellow). (A) Crystal structure (PDB id 1HZH85) and (B) Schematic drawing
of a full IgG antibody. Antigen binding domains are indicated by stars (*). (C)
Crystal structure of a FAB in complex with an antigen (red). PDB id 1A3R86. (D)
Top view of the antigen binding pocket of the FAB.
a second diversification step called somatic hypermutation (i.e. actively mutat-
ing the variable gene segments) spawns a second generation of B-cells secreting
further refined versions of the final antibody89. This process of generating an
almost infinite number of antibodies which specifically bind to different antigens
allows higher organisms to keep up with the high mutation rate of pathogenic
microorganisms and viruses.
The immune system can generate specific antibodies against almost any kind
of target molecule. This can be exploited to produce tailored antibodies (e.g.
for detection) by injecting an animal with the molecule of interest together with
some substances that stimulate an immune response. A polyclonal antibody, i.e.
a mixture of different antibodies produced by different B-cells against the same
molecule can now be extracted directly from the serum of the animal90. However,
if binding to a specific domain of the target molecule is desired (i.e. to produce an
inhibitory antibody) or if large quantities of antibody are needed, a monoclonal
antibody (i.e. an antibody derived from a single B-lymphocyte, binding only to
one specific site of the antigen) is required. To produce a monoclonal antibody,
single B-cells are immortalized (i.e. modified so that they can multiply indefinitely)
12
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and single clones are selected for the desired antibody properties91. Now these
B-cells can be grown in cell culture to produce large amounts of antibody.
In 1991, Winter and Milstein 92 concluded their visionary review, titled ”Man-
made antibodies”, with the words ”In the immediate future most [antibody
creation methods] will start with immunized animals”. However, it was only 1
year later that Gram et al. 93 were successful in creating a FAB fragment without
the need of animal immunization. For these completely ”man-made” antibodies,
large libraries containing ≥ 1010 different FABs are screened by a technique
called ”phage display”. For this technique, each FAB is expressed on the surface
of a bacteriophage which carries the gene for this FAB in its genome. That
way, the FAB protein and the gene encoding for it are physically linked together.
Bacteriophages carrying a FAB specific for the desired antigen can then be selected
by several rounds of affinity purification. Compared to the standard methods for
creating a monoclonal antibody, this technique is faster, more flexible (especially
for creating therapeutically relevant human antibodies94) and does not require
animal experiments.
Aptamers
RNA and DNA can produce a wide variety of three dimensional structures which
can even have catalytic activity95,96. Therefore, it was only logical that the
principle of physically combining the antigen binding molecule and the gene
encoding for it was extended by the creation of ”aptamers”. Aptamers are small
single stranded DNA or RNA molecules generated via ”systematic evolution of
ligands by exponential enrichment” (SELEX; see figure 1.7A)97. This process is
conceptually very similar to phage display, except that the DNA does not only
encode for the binding molecule, but is the binding molecule.
The SELEX process starts with a library of oligonucleotides which consist of
a known starting sequence, a random sequence of 40–60 basepairs followed by
a known ending sequence (figure 1.7A 1). These libraries usually contain 1015
different oligonucleotides which are selected for their binding specificity by affinity
purification (figure 1.7A 2–4). After each purification step, the oligonucleotides
that bound (enriched pool) to the target can be amplified by polymerase chain
13
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reaction (PCR), using primers against the known starting and ending regions
(figure 1.7A 5).
5’-GGUGUCU UG GA G
UGC
UGA 
UC  GGACACC-3’
B
A
C
1. Randomized
starting pool
Enriched
pool
2. Selection by target binding
6. Isolation of high-
affinity nucleic acid
3. Washing out un-
bound nucleic acid
4. Elution
7. Refined
aptamer
5. PCR Amplification
After
several
rounds
Figure 1.7: Creation of aptamers - (A) Creation of high affinity aptamers
using systematic evolution of ligands by exponential enrichment. Adapted from
Rimmele 98 . (B) NMR structure (PDB id 484D99) of an example RNA aptamer in
complex with its target peptide (red). (C) Sequence of the example aptamer.
This process of amplification and selection can be repeated several times to
yield aptamers with dissociation constants of Kd ≈10−9 M−1 comparable to the
best monoclonal antibodies (figure 1.7A 6). An aptamer can then be further
refined by shortening it to the minimal required oligonucleotide (i.e. usually
cutting off the constant regions; figure 1.7A 7). The structure of an example
aptamer in complex with its target peptide is shown in figure 1.7B and C. Though
not yet anywhere nearly as available as antibodies, an aptamer sequence, once
14
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identified, is easily synthesized and tagged with fluorescent dyes or chemical tags,
i.e. can be ordered like any custom made DNA primer.
1.3 Biomolecules for nanotechnology
A
B
Figure 1.8: Microtubules transporting cargo on a kinesin-1 coated sur-
face - Microtubules are propelled over the surface by immobilized kinesin-1 motors
in the presence of ATP. Cargo (e.g. quantum dots) is picked up at point (A)
and moved to point (B). Courtesy of Franziska Friedrich, Max Planck Institute of
Molecular Cell Biology and Genetics, Dresden.
Technology has often made great advances by imitating biological systems.
The most prominent example for such an advance is the imitation of bird flight by
air planes. Imitating, or even using biological systems is especially promising for
nanotechnology. As the examples discussed in the previous section show, many
proteins work as nanoscopic machines. They are usually only a few nanometers in
size and have been optimized by evolution to fulfill their designated task with ex-
tremely high efficiency, specificity and precision. With our growing understanding
of the biophysics of these proteins, this wealth of nano-machines can be tapped
and used for nanotechnology. In the case of kinesin-1 and microtubules, the most
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promising assay towards this end is the so-called ”gliding motility assay”, a setup
where microtubules are propelled by surface-attached motor proteins in a way
reminiscent of crowd surfing (see also figure 1.8). Using this in vitro assay, proof-
of-principle studies have already successfully demonstrated transport22,29,100–106,
sorting19,107 and detection108–110 of nano-sized cargo.
Specific cargo binding
Microtubule
Kinesin-1
antibody
Streptavidin
Biotin
A B
Figure 1.9: The biotin-streptavidin bond - (A) Structure of streptavidin
(green) in complex with biotin (red). PDB id 2RTR111. Only the top two subunits
of the tetramer are shown. (B) Scheme of binding a biotinylated antibody via
streptavidin to a gliding microtubule.
Transport of cargo in a gliding assay requires specific binding between cargo
and cytoskeletal filament. Ideally, this binding should be specific, stable and
reversible. A common issue with all binding strategies is that cargo and motors
share the microtubule lattice and will probably compete for binding sites. The
implications of this will be discussed in chapter 2.
The most common method for the attachment of cargo to microtubules em-
ploys the biotin-streptavidin interaction22,29,102,104,106,108–110,112–114. Streptavidin is
a highly stable, tetrameric molecule that specifically binds biotin with an extraor-
dinary high affinity (Kd ≈10−14 M−1)111,115 (figure 1.9A). Due to the fact, that
streptavidin has four binding sites for biotin, it can also be used as a cross-linker,
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connecting biotinylated microtubules to biotinylated cargo (figure 1.9B). Most
proteins, including antibodies can be covalently labeled with amino-reactive bi-
otin without disrupting their activity. Such labeling is usually done via amino-
(−NH2), carboxy- (−COOH) or sulfhydryl-reactive (−SH) chemistry targeting
specific amino acid side chains on the protein116 (table 1.1).
Table 1.1: Covalent modifications of proteins - Amino acids with side chain
functionalities suitable for specific covalent modification by reactive groups.
Amino acid Side chain functionality Reactive group
Lysine −NH2 active ester (NHS, TPF)
Amino terminus epoxy
aldehyde
Cysteine −SH maleimide
pyridyil disulfide
vinyl sulfone
Aspartate −COOH amine + reduction
Glutamate
Carboxy terminus
Serine −OH epoxy
Threonine
Which side chain should be targeted is determined by the properties of the
protein and by the desired labeling ratio. The achieved labeling ratio will greatly
depend on how many side chains of the targeted type are surface accessible.
Considering the varying frequencies of the corresponding amino acid(s)117 and
the polarity of the side chain (less polar side chains are more likely to be hidden
inside the protein84) the frequency with which the side chain functionalities appear
on the surface of proteins is estimated to be in the following order: −COOH >
−NH2 > −OH  −SH. Consequently, carboxy- and amino-reactive chemistries
generally result in higher labeling ratios than sulfhydryl-reactive chemistryi. On
iThe only available hydroxy-(−OH)-reactive group also reacts with amines. Therefore, −OH
chemistry will not be discussed separately here.
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the other hand, ”site-specific” labeling (i.e. labeling that targets a specific amino
acid or domain of the protein) can only be achieved using thiol-reactive groups.
Due to the low abundance of cysteine in proteins, site-specific labeling can be
used to specifically label a desired position of a so-called ”cys-light” mutant, i.e.
a mutant that has no surface accessible cysteine residues except for one at the
desired target site31,75. Also, the specific target protein may have certain side
chains that are crucial for its function and therefore should not be modified (e.g.
serine-proteases84). However, sometimes specific inactivation results in a desirable
behavior as is the case for maleimide-modified tubulin, which blocks growth from
the minus-end of microtubules118. The two most commonly used reactive groups
are N-hydroxy-succinimidyl (NHS) esters for amino groups and maleimide for
sulfhydryl groups. The respective reactions are shown in figure 1.10.
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Figure 1.10: Amino- and Sulfhydryl-specific chemistry - (A) Reaction of a
NHS ester with a primary amine (e.g. the side chain of a lysine). (B) Reaction of a
maleimide with a sulfhydryl group (the side chain of a cysteine).
Using bifunctional linkers, i.e. linkers containing reactive groups on both ends,
this chemistry can also be used to covalently bind cargo to microtubules. A covalent
bond could be desirable in the case of antibodies linked to the microtubules to
facilitate molecular detection.
Spatial and temporal control
The most important requirement for nanotechnological applications of molecular
motors is external control. Just like macroscopic machines have interfaces allowing
a user to manage them, we need possibilities to interface with biomolecules in
18
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order to control their various activities. The higher the complexity of a desired
application, the more control over the individual components performing the task
is required. For example, a light bulb requires only one switch to appropriately
perform its single task, while a modern computer requires a whole operating system
with a graphical user interface to perform complex calculations (e.g. molecular
modelling). Likewise, precise control mechanisms are of highest priority for the
application of biomolecular motors in nanotechnology. The most basic activity
that needs to be managed is the interaction between biomolecule and the target
that is to be manipulated. In the simplest version of a gliding assay without any
means of control, microtubules are propelled randomly in all directions (see figure
1.8, ignore guiding barrier). However, even in this setup, interesting observations
can be made, if specific cargo binding is achieved (see the previous section). For
example: stretching of DNA119, spontaneous formation of ordered microtubule
bundles and spools113 and transport of virus particles101.
The next logical step towards more complex nanotechnological applications of
biomolecules is to acquire spatial- (i.e. steering motility) and temporal control
(i.e. starting and stopping motility). Spatial guiding has been accomplished
by surface structuring16,24,121 (figure 1.11A) or chemical patterning28,121 (figure
1.11B). Especially the latter approach is very interesting: Reuther et al. 28 showed,
that efficient guiding of microtubule gliding on surfaces can be achieved simply
by restricting kinesin-1 to narrow tracks. This can be explained by a peculiar
feature of the kinesin-1-microtubule transport system: microtubules will only
leave patterned kinesin-1 tracks if the angle is above a certain threshold121.
Consequently, if a track is narrow enough that microtubules cannot achieve
angles above this threshold, guiding is efficient. Temporal control, i.e. switching
motility on and off was achieved using thermo-responsive polymers grafted to the
surface (figure 1.11C). Ionov et al. 26 showed that these polymers repel microtubules
from the surface when the polymer is swollen below its lower critical solution
temperature (LCST). Upon heating above the LCST the polymer collapses and
allows gliding motility. Another approach granting temporal control managed to
start and stop gliding microtubules using microfluidics and the slowly hydrolyzable
ATP analog adenosine 5’-[β,γ-imido] triphosphate (AMPPNP)25 (figure 1.11D).
A combination of spatial and temporal control was achieved in a sorting device
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Figure 1.11: Examples of control over microtubules - (A) Guiding by surface
topography. Adapted fromvan den Heuvel et al. 24 . (B) Guiding by chemical
patterning. Adapted fromReuther et al. 28 . (C) Microtubule release from the
surface by thermally switchable polymers. Adapted from Ionov et al. 26 . (D)
Stopping gliding microtubules by the slowly hydrolyzable ATP analog AMPPNP.
Adapted from Gast et al. 25 . (E) Sorting of microtubules using guiding channels and
electrical fields. Adapted from van den Heuvel et al. 19 . (F) Localized activation
of microtubule gliding by light-induced release of ATP from caged ATP. Adapted
from Tucker et al. 120 . (G) Prototype of a ”smart dust” biosensor. Adapted from
Fischer et al. 110 . (H) Detection by microtubule speed (see chapter 3).
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using a combination of surface topography and steering by electrical fields19
(figure 1.11E). Not demonstrating a concrete device, but using an intriguing novel
approach, Tucker et al. 120 demonstrated local activation of microtubule gliding by
photolysis of caged-ATP. To increase both spatial and temporal resolution, they
added an enzyme sequestering the rapidly diffusing ATP (figure 1.11F).
The examples of control mechanisms discussed above show that using biomolec-
ular motors are promising actuators for nanotechnology. The envisioned goal is
to provide a toolbox that future nano-engineers can use and combine to create
nano-appliances. However all control approaches proposed so far still lack flexibil-
ity and/or precision. For example, adding AMPPNP to inhibit kinesin-1 can be
compared to melting the asphalt of an entire road in order to stop a car. Therefore,
it is not surprising, that the first proof of principle applications do not rely heavily
on precise control. The most recent and at the same time the most technically
mature appliance using biomolecular motors is a ”smar dust” biosensor109,110
(figure 1.11G). The device elegantly miniaturizes the well established principle
of a double antibody sandwich assay. Analyte is captured by antibody coated
microtubules in the central area of the device (dark grey circle in figure 1.11G). As
soon as the device is exposed to light, ATP is released and the microtubules start
to move randomly on the surface. When they accidentally move into the outer
area (light grey circle) which contains a tagged secondary antibody, the tag is also
picked up by the microtubule. The detection is then achieved in the outermost
area (green circle) where the microtubules get stuck and thus are concentrated.
Another detection scheme will be presented in chapter 3. Briefly, this scheme
relies on the detection of speed changes depending on the density of analyte bound
to gliding microtubules (figure 1.11H).
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In vitro reconstitution of
transport on crowded
microtubules
As discussed in section 1.3, kinesin-1 motors are promising components for the
setup of molecular sorting, nano-assembly and detection devices19,26,105,110,122. In
particular, in vitro transport assays often utilize the geometry of gliding motility
where kinesin-1 is adsorbed onto a substrate surface and propels microtubules in
the presence of ATP123. Nano-sized cargo is then most commonly attached to these
gliding cytoskeletal filaments via biotin and streptavidin22,29,102,104,106,108–110,112–114.
While motile microtubules provide a versatile platform for attachment of transport
material, cargo and motor protein share the microtubule lattice as a common
substrate. Therefore, it is likely, that the cargo acts as an obstacle for the kinesin-1
motors that propel the microtubule. The central question this chapter tries to
answer is: ”What happens to molecular motors when they encounter obstacles?”
To pursue this question, the existing minimalistic in vitro system was extended
by streptavidin molecules serving as model roadblocks for the motor proteins.
With this system it was possible to propose a mechanism explaining the effects of
roadblocks on cargo transport by single and multiple motor proteins. Some of
the results presented in this and the next chapter have already been published in
similar form in Korten and Diez 108
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2. IN VITRO RECONSTITUTION OF TRANSPORT ON
CROWDED MICROTUBULES
2.1 Single motor proteins at obstacles
In order to be able to resolve transient molecular interactions between single
kinesin-1 molecules and obstacles, a high spacial and temporal resolution is
required. Therefore, total internal reflection (TIRF) microscopy was used to
observe single kinesin-1 molecules labeled with green fluorescent protein (GFP).
Biotinylated microtubules were attached to the glass surface via anti-β-tubulin
antibodies (figure 2.1). Trajectories of moving kinesin-1 molecules (rkin430GFP
see section 6.3) were evaluated in space-time plots (”kymographs”) before and
after incubation with streptavidin.
Figure 2.1: Single molecule roadblock assay - Single GFP-labeled kinesin-1
molecules are observerd moving along streptavidin-coated microtubules that are
fixed to the surface via anti-β-tubulin antibodies.
Single kinesin-1 molecules stop at obstacles
Figure 2.2A shows typical kymographs of individual GFP-kinesin-1 molecules
stepping on biotinylated and streptavidin-coated microtubules. While control
measurements on non-biotinylated microtubules (or biotinylated microtubules
without streptavidin treatment) showed trajectories characteristic for kinesin-1
(speed of 0.7± 0.1 µm/s, typical for the low salt concentration (BRB20) used
in this assay), a less robust motility was identified for increasing streptavidin
decoration. In order to perform a quantitative analysis of this behavior, the
different motility events were classified in the following manner (figure 2.2B): a
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Figure 2.2: Kinesin-1 on streptavidin coated microtubules - (A) Typical
kymographs of single kinesin-1 molecules running on microtubules with different
biotinylation ratios (after streptavidin incubation). Time is progressing from top
to bottom, while the motors (dark signals) move along a surface-immobilized
microtubule from left to right. Small images below each kymograph show how its
space dimension was derived from a line drawn across the corresponding microtubule.
(B) Classification of the different motility events. (C) Ratio of integrated moving
time to total dwell time (moving time+non-moving time) of all kinesin-1 binding
events (usually around 80) per microtubule. Each data point represents an average
over 6 microtubules, weighted by the total dwell time. Error bars represent unbiased
estimators for the population standard deviation (n = 6).
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”moving kinesin-1” translated with constant speed, a ‘non-moving kinesin-1’ did
not change its position, a ”stopping kinesin-1” switched from the moving to the
non-moving state, a ”starting kinesin-1” switched from the non-moving to the
moving state and a ”pausing kinesin-1” stopped first and started to move again
later.
Based on this classification, the ratio of integrated moving times to total
dwell times was plotted as a function of the microtubule biotinylation ratio
(figure 2.2C). Before incubation with streptavidin, no significant dependence on
biotinylation ratio was observed. In contrast, after microtubules were incubated
with streptavidin, the number of non-moving and stopping kinesin-1 molecules
significantly increased. Hence the relative time kinesin-1 molecules spent in
running phases (and such the plotted ratio) decreased with increasing streptavidin
coating density. However, in-between stopping events most of the motors moved
at full speed, independent of the presence of streptavidin on the microtubules.
Observing kinesin-1 stopping at roadblocks with nanometer
resolution
Unlabeled obstacles were used for the experiments shown in the previous section.
Therefore, it was not possible to test if the stopping positions of individual
GFP-kinesin-1 molecules correlated with the locations of obstacles. To show
that kinesin-1 really stops at the position of the obstacle, stepping experiments
with streptavidin-coated quantum dots124 (Qdots, emission wavelength 655 nm)
attached to the microtubule lattice were performed. Using a dual-color emission
beam-splitter, Qdots and GFP-kinesin-1 molecules were tracked simultaneously
with a tracking software (FIESTA) developed by Felix Ruhnow, a colleague in the
lab125. The tracking accuracy for individual Qdots and GFP-kinesin-1 molecules
was estimated to be 7 nm and 30 nm, respectively.
A typical example of an encounter between a GFP-kinesin-1 molecule and
a Qdot is provided in figure 2.3. The x-y trajectories (figure 2.3A) clearly
show that the GFP-kinesin-1 molecule (green trace) ran in a straight line until
it encountered a Qdot (red trace). The motor then stopped for a while and
continued running eventually. For a better illustration of the temporal component,
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Figure 2.3: Nanometer tracking - A typical encounter between a GFP-kinesin-1
molecule and a Qdot roadblock. (A) x-y trajectories of the GFP-kinesin-1 molecule
(green) and Qdot (red).The microtubule position was estimated by linear regression
of the GFP-kinesin-1 data (dotted line). (B) Distance of the GFP-kinesin-1 molecule
and the Qdot along the microtubule (relative to the average position of the Qdot)
plotted against time. The dual color kymograph, derived from the widefield TIRF
imaging was put transparently in the background for comparison.
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the distance of both trajectories from the average Qdot position was plotted
against time in a kymograph-like manner (figure 2.3B). To calculate the distance
along the microtubule, all tracked positions were projected onto the direction of
the microtubule, derived from a linear regression of GFP-kinesin-1’s x-y data.
Roadblocks and processivity
Seeing that single kinesin-1 motors stop at obstacles leads to the question how
this affects kinesin-1’s processivity. Together with a bachelor student, Oliver
Wüseke, kinesin-1 molecules were observed in single molecule stepping assays
with- and without streptavidin roadblocks. Using FIESTA, the positions of these
molecules were tracked with ∼50 nm precision. This precision is lower compared
to the data shown in the previous section because the illuminating laser power
was reduced. Consequently the lower photon count per pixel per frame led to
a reduced tracking accuracy126. The lower accuracy was accepted in favor of
reduced bleaching artifacts and a longer lifetime of the fluorophores.
The tracked molecule positions were analyzed for the time the molecules
interacted with the microtubule (dwell time, τ) and the distance the molecules
traveled along the microtubule (run length, L). As expected for a processive
motor protein, both dwell times (figure 2.4A and B) and run lengths (figure 2.4C
and D) were distributed exponentially. Therefore, characteristic values for the
observed dwell times (τobs) and run lengths (Lobs) were obtained by fitting single
exponential functions to the data. Using the bleaching time (τbl) measured for each
experiment (figure 2.4E), these observed values were corrected for bleaching as
described in section 6.4 and are shown in figure 2.4F. The corrected characteristic
dwell time without streptavidin roadblocks was τ− = 2.0± 0.2 s. This value was
decreased by 57 % in the presence of roadblocks (τ+ = 0.86± 0.08 s). An even
stronger effect was observed for the corrected characteristic run length which was
decreased by 73 % from L− = 1.4± 0.2 µm to L+ = 0.37± 0.04 µm.
In all single molecule experiments with roadblocks presented in this chapter,
it was observed that most molecules moved at full speed between stopping events.
This leads to the hypothesis, that the lower average speed in the presence of
roadblocks (v̄+) is the result of an averaging of two independent phases: The
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Figure 2.4: The effect of obstacles on dwell time and run length of single
kinesin-1 molecules in BRB20 - Histograms of dwell times (A and B) and run
lengths (C and D) of single kinesin-1 molecules without- (-SA) and with (+SA)
streptavidin. Histograms were fitted with single exponential functions excluding
the first bin due to a limited time resolution. The obtained characteristic values
of dwell times (τobs) and run lengths (Lobs) were corrected for bleaching using the
characteristic bleaching time τbl derived from a histogram of bleaching times (E; see
also section 6.4). The resulting corrected characteristic dwell times (τ−; τ+) and
characteristic run lengths (L−; L+) are shown in a bar chart (F). All errors given
are ± one standard deviation.
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motor’s normal running phase (v̄−) and a stopping phase. Thus, the probabilities
to be in a running phase (Pr) can be calculated (equation 2.1).
v̄+ = v̄− ·Pr (2.1)
In the following, individual dissociation rates for the running phase (koff ) and
the stopping phase (ks) are assigned. Assuming that these rates are not influenced
by each other, the dissociation rate observed in the presence of obstacles (k+) can
be expressed as the sum of koff and ks. Since the probability for an individual
molecule to be running or to be stopping is not equal, koff and ks have to be
weighted by the respective probabilities to be in a stopping or in a running phase
(equation 2.2).
k+ = (koff ·Pr) + (ks · (1− Pr)) (2.2)
Now, the kinetic parameters with and without obstacles, including the dissociation
rate at an obstacle (ks, equation 2.3) can be calculated from the measured dwell
times (τ−, τ+) and run lengths (L−, L+) (table 2.1).
ks =
L− − L+
τ+ ·L− − τ− ·L+
(2.3)
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Table 2.1: Measured and calculated kinetic parameters of kinesin-1 at
roadblocks - Figures illustrating the conditions under which the parameters were
measured; from top to bottom: no obstacles (-), with obstacles (+) and only
stopping or pausing events. For each condition, the directly measured parameters
and the parameters calculated from the measured ones are listed. The respective
errors were estimated using Gaussian error propagation (see section 6.4).
Condition Measured Calculated
τ−; L− v̄− =
L−
τ−
; koff =
1
τ− Pr =
v̄+
v̄−
;
τ+; L+ v̄+ =
L+
τ+
; k+ =
1
τ+
ks = (eqn.
2.3)
τstop; τpause
kstop =
1
τstop
;
kcontinue =
1
τpause
Table 2.2: Kinetic parameters of kinesin-1 in BRB20 at roadblocks -
Values were calculated according to table 2.1 and section 6.4 from the measured
dwell times and run lengths shown in figure 2.4.
v̄− = 0.7 ± 0.1 µm/s
v̄+ = 0.43 ± 0.06 µm/s
Pr = 0.6 ± 0.1
koff = 0.50 ± 0.05 s−1
k+ = 1.2 ± 0.1 s−1
ks = 2.3 ± 0.8 s−1
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Figure 2.5: The effect of obstacles on dwell time and run length of single
kinesin-1 molecules in BRB80 - Histograms of dwell times (A and B) and run
lengths (C and D) of single kinesin-1 molecules without- (-SA) and with (+SA)
streptavidin. Hisograms were fitted with single exponential functions excluding
the first bin due to a limited time resolution. The obtained characteristic values
of dwell times (τobs) and run lengths (Lobs) were corrected for bleaching using the
characteristic bleaching time τbl derived from a histogram of bleaching times (E; see
also section 6.4). The resulting corrected characteristic dwell times (τ−; τ+) and
characteristic run lengths (L−; L+) are shown in a bar chart (F). All errors given
are ± one standard deviation.
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It has been shown, that buffer salt concentration has a strong effect on
kinesin-1’s run length and dwell time127. Therefore, the effect of roadblocks on
kinesin-1’s kinetic parameters was also analyzed in a buffer containing a medium
salt concentration (BRB80; see figure2.5). The whole experiment, including data
evaluation, was performed analogous to the experiment in BRB20 described be-
fore. The two exceptions are the different buffer conditions and an increased time
resolution for the experiment with obstacles (20 frames/s instead of 10 frames/s)
to account for the lower dwell times. In these buffer conditions, the corrected
characteristic dwell time without streptavidin roadblocks was τ− = 0.9± 0.1 s.
Like in BRB20, this value was decreased about twofold (by 54 %) in the pres-
ence of roadblocks (τ+ = 0.47± 0.08 s). Also the characteristic corrected run
length behaved similar, being decreased by 77 % from L− = 0.4± 0.08 µm to
L+ = 0.11± 0.04 µm. The corresponding kinetic parameters calculated from
these run lengths and dwell times are summarized in table 2.3.
Table 2.3: Kinetic parameters of kinesin-1 in BRB80 at roadblocks -
Values were calculated according to table 2.1 and section 6.4 from the measured
dwell times and run lengths shown in figure 2.5.
v̄− = 0.5 ± 0.1 µm/s
v̄+ = 0.3 ± 0.1 µm/s
Pr = 0.5 ± 0.2
koff = 1.1 ± 0.1 s−1
k+ = 2.3 ± 0.3 s−1
ks = 3.6 ± 1.5 s−1
Surprisingly, the average speed in BRB80 (0.5± 0.1 µm/s) was slightly slower
than in BRB20 (0.7± 0.1 µm/s). This is in contrast to previous results showing
that kinesin-1 is slightly faster at high salt concentrations127. This discrepancy
could be explained by the fact that in the BRB80 experiments shown here, a
higher motor concentration was used than in BRB20 to compensate for the lower
landing rate in high salt buffer. However, this increase in motor concentration
led to an increased unspecific binding of motors to the surface, resulting in some
observed stopping events even without roadblocks. These stopping events can
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Figure 2.6: Direct measurement of
stopping times in BRB20 - (A, C) Ex-
ample traces of stopping and pausing events,
respectively. The times that would be
counted for these events are shown in red.
(B) Histogram of stopping times with the
exponential function fitted to the data. (D)
Histogram of pausing times with the respec-
tive exponential fit. Stopping (A and B)
and pausing times (C and D) were mea-
sured directly from kymographs taken from
the same data that was used for figure 2.4.
Characteristic stopping- (τstop) and pausing
(τpause) times and the corresponding disso-
ciation rates (kstop and kcontinue) derived
from the fits are shown in the insets. Errors
are ± one standard deviation.
usually be ignored as artifacts. However in order to be able to compare the control
without roadblocks (which should not show stopping events) with the experiments
containing roadblocks (which are expected to show stopping events) the stopping
events in the control were included into the evaluation resulting in a lower average
speed. The average speed without the stopping events was 0.8± 0.1 µm/s as
expected under these conditions (data not shown).
To test whether the assumptions made to calculate ks were correct, the
calculated value could be compared to a direct measurement. To do this, the
dwell times that motors spent in a stopping phase (i.e. the stopping times) were
measured in kymographs taken from the same data that was used for dwell time
and run length analysis in BRB20. Only events where motors were leaving the
microtubule directly out of a stopping phase were evaluated (see figure 2.6A for
example traces). All stopping times were plotted in a histogram and fitted with
an exponential function. The dissociation rate in the stopping phase (kstop) was
then calculated as the reciprocal of the characteristic stopping time (τstop) given
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by this exponential fit. The directly measured value for kstop (2.1± 0.1 s−1) is in
very good agreement with the calculated value ks (2.3± 0.8 s−1; see table 2.2).
Some observed stopping events might have disappeared due to bleaching and
therefore kstop might be slightly overestimated. However, the effect of bleaching is
expected to be small, since the total dwell times were around 0.8 s and thus much
lower than the bleaching time of 12.3 s (figure 2.4B and E).
In a similar fashion the times that kinesin-1 motors spent in a stopping phase
before continuing to run (pausing dwell times; see figure 2.6C for example traces)
were evaluated. The resulting rate, kcontinue (2.1± 0.1 s−1), was almost exactly
the same as kstop measured in the stopping phase.
2.2 Effects of obstacles on multi-motor trans-
port
The effect of obstacles on single kinesin-1 molecules could be studied quite well
in the stepping geometry described in the previous section. However, it has
been shown that cargo transported by multiple kinesin-1 motors behaves quite
different from cargo transported by single motors: Multiple motors create more
force, move the cargo over longer distances without detaching and in smaller
steps125,128,129. To investigate how the effect of obstacles on the motility of single
molecules described in section 2.1 relates to cargo transported by multiple motors,
systematic gliding motility experiments were performed. Apart from being an
established tool for in vitro studies of motor proteins, this setup has the additional
advantage that it is highly promising for nanotechnological molecular transport
assays19,105,107,122. Therefore, the results presented here will have implications for
the nanotechnological application of motor proteins (see also chapter 3).
Gliding motility assay
As depicted in figure 2.7, a gliding motility assay is basically an inverted stepping
assay: Many motor proteins are adsorbed onto a substrate surface and propel
cytoskeletal filaments in the presence of ATP123,130,131. The impact of obstacles on
the gliding speed of rhodamine labeled, biotinylated microtubules was studied by
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Figure 2.7: Microtubule gliding assay - Microtubules coated with fluorescein-
streptavidin are gliding over a kinesin-1-coated surface.
loading them with varying amounts of fluorescein-labeled streptavidin (FSA). The
streptavidin density on the microtubule lattice was varied either (i) by varying the
microtubule biotinylation ratio and adding a fixed (saturating) amount of FSA
(figure 2.8A and B) or (ii) by using a fixed biotinylation ratio and varying the
FSA concentration (figure 2.8C and D). For all FSA concentrations used in this
second experiment, FSA was in excess compared to the estimated amount (1 nM)
of biotin binding sites on the microtubules. However, the biotin binding sites
were only saturated within the given incubation time at 10 µM FSA as observed
by the clustering of motile microtubules at lower FSA concentrations. This is
indicative of a varying FSA density on the microtubules. The reason why such a
high excess of FSA was necessary is probably because surface-bound microtubules
are not very well accessible within the relatively short incubation time of 10 min
and because FSA had a lowered activity due to freezing of FSA aliquots prior to
use. Images were acquired by fluorescence microscopy in the rhodamine and in
the fluorescein channel (figure 2.8A and C).
Microtubule gliding speed depends on streptavidin coating
density
Figure 2.8, panels B and D show the gliding speeds before (open squares) and after
(open circles) FSA treatment. The actual FSA coating density was estimated from
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Figure 2.8: Streptavidin coating slows down gliding microtubules - (A),
(C) Fluorescence images of FSA-coated, rhodamine-labeled microtubules in the
rhodamine (red) and fluorescein (green) channels. (B), (D) Gliding speeds of
microtubules before (black, open squares) and after (black, open circles) FSA
incubation (mean ± s.d., n = 20). Corresponding FSA fluorescence intensities are
shown as green, filled triangles (right axes, mean ± s.d, n = 6). In (A) and (B)
microtubules with various biotinylation ratios were incubated with 10 µM FSA. In
(C) and (D) microtubules with a fixed biotinylation ratio of 1 : 4 were incubated
with varying concentrations of FSA.
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Figure 2.9: Microtubule speed depends on streptavidin coating density
- The microtubule speed data from figure 2.8B and D open circles plotted against
the corresponding FSA fluorescence intensities (data from figure 2.8B and D, green
filled triangles). Error bars represent the mean ± s.d. (n = 20 for the speed data;
n = 6 for the intensity data).
the green fluorescence intensity of the coated microtubules (green, filled triangles).
Before incubation with FSA, no significant dependence of microtubule speed
on biotinylation ratio was observed. On the other hand, after FSA incubation,
a significant decrease in microtubule speeds with increasing FSA ”decoration”
occurred. This shows that small molecules like rhodamine or biotin do not
impact microtubule gliding. However, molecules that are in the size-range of
motor heads — like streptavidin — are able to hinder microtubule movement. A
clear dependence of microtubule speed on FSA coating density was confirmed by
plotting microtubule speeds (data from figure 2.8B and D, open circles) against
the corresponding FSA fluorescence intensities (data from figure 2.8B and D, green
filled triangles). This plot shows that an increase of streptavidin coating density
leads to a predictable decrease in speed (figure 2.9). Due to high insecurities in
the fluorescence intensity measurements, the nature of the dependence could not
be determined with certainty. A linear and an exponential fit resulted in very
similar χ2red values of 0.67 and 0.68, respectively. While a linear dependence agrees
very well with the speeds observed in a biotinylation range form 0 – 0.25 (figure
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2.8B) the relation is likely to get much more complex for higher obstacle densities,
where the speed approaches zero.
2.3 Discussion
The effects of obstacles on the stepping of kinesin-1 have been studied from different
points of view by various research groups, resulting in different conclusions:
Some studies indicated that kinesin-1 mainly releases when encountering an
obstacle132–134, while others showed that kinesin-1 stops108,135. How this apparent
contradiction can be resolved will be discussed in the following.
Table 2.4: Comparison of kinetic parameters of kinesin-1 at roadblocks
in different salt concentrations - Values were calculated according to table 2.1
and section 6.4 from the measured dwell times and run lengths shown in Telley
et al. 134 (BRB12, errors estimated from graphs), figure 2.4 (BRB20) and figure
2.5 (BRB80). The indices parameter− and parameter+ denote parameters without
and with roadblocks, respectively.
Parameter BRB12134 BRB20 BRB80
τ− (s) 1.8 ± 0.3 2.0 ± 0.2 0.9 ± 0.1
τ+ (s) 1.4 ± 0.2 0.86 ± 0.08 0.43 ± 0.05
L− (µm) 1.2 ± 0.1 1.4 ± 0.2 0.47 ± 0.08
L+ (µm) 0.7 ± 0.3 0.37 ± 0.04 0.11 ± 0.04
v̄− (µm/s) 0.7 ± 0.1 0.7 ± 0.1 0.5 ± 0.1
v̄+ (µm/s) 0.5 ± 0.2 0.43 ± 0.06 0.3 ± 0.1
Pr 0.8 ± 0.4 0.6 ± 0.1 0.5 ± 0.2
koff (s
−1) 0.56 ± 0.08 0.50 ± 0.05 1.1 ± 0.1
k+ (s
−1) 0.73 ± 0.08 1.2 ± 0.1 2.3 ± 0.3
ks (s
−1) 1.3 ± 1.2 2.3 ± 0.8 3.6 ± 1.5
kstop (s
−1) 2.1 ± 0.1
kcontinue (s
−1) 2.1 ± 0.1
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Stopping or dissociation? That kinesin-1 indeed stops at obstacles could
be clearly confirmed by observing kinesin-1 stopping at Qdots with nanometer
resolution and by single molecule experiments with varying obstacle densities (see
section 2.1). At a first glance, these results contradict the findings indicating that
kinesin-1 releases when encountering an obstacle132–134. However, analyzing the
dwell time and run length of kinesin-1 revealed, that kinesin-1’s dissociation rate
is strongly increased despite the many observed stopping events. This shows that
both stopping and an increased dissociation of the motors happen at the same time.
That the results shown in section 2.1 are, in fact, consistent with single molecule
results that were interpreted as mainly dissociating events by Telley et al. 134 can be
seen in table 2.4. Average speeds, dwell times and run lengths without roadblocks
(v̄−, τ−, L−) are almost identical and agree well with other published results
73,127.
Interestingly, the reduction in dwell time (24 %) and run length (43 %) observed
by Telley et al. show the same tendencies, but are less pronounced than what
was observed here (57 % and 73 %, respectively). This could be explained by a
lower obstacle density in their assay, which would also explain why they observed
less stopping events. In contrast, the ks measured here under steady state single
molecule conditions is roughly an order of magnitude lower than the 42 s−1
measured previously by Crevel et al. 132 in flash photolysis and light scattering
experiments. This difference could be attributed to the fact that light scattering
experiments use very highly decorated microtubules (up to one motor every two
tubulin dimers) and measure relaxation into equilibrium136. This would also
explain their very high dissociation rate of 18.6 s−1 measured without roadblocks.
This dissociation rate corresponds to a processivity of ≈ 2.5 steps, which is about
40 times lower than the processivity measured for single molecules59,73.
The model: Kinesin-1 stopping at roadblocks can be explained by the following
model based on its particular properties: Kinesin-1 moves in a hand-over-hand
mechanism along a single protofilament64,137,138. Its processivity requires the rear head
to stay bound until the leading head is firmly attached to the next tubulin dimer along
the protofilament12,70. Therefore, if a large molecule is blocking the next tubulin dimer,
the leading head cannot bind, while the rear head remains bound. This situation
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effectively stalls the kinesin-1 molecule. This model for the stopping mechanism
makes two predictions:
1. Kinesin-1 stays stopped at an obstacle until it dissociates or until its forward
head is able to bind to another binding site.
2. The observed reduction of the average velocity of kinesin-1 in the presence
of obstacles is due to a combination of running phases and stopping phases.
Additionally, applying the rule of simplicity, it was assumed that the roadblocks
do not have any other effect than the one described above which adds the following
assumption:
• Moving and stopping phases are independent of each other and thus:
a. Kinesin-1 moves at its full speed between stopping phases.
b. The dissociation rate during running phases is the same as kinesin-1’s
unperturbed koff .
One observation supporting these predictions is that most molecules move at
full speed between stopping events. Even more convincing is the fact, that the
dissociation rate ks, which was calculated based on these predictions (equation
2.3), is in very good agreement with the dissociation rate kstop that was measured
directly (see table 2.4).
ks plotted against dwell times and run lengths: In order to better under-
stand how — based on the proposed model — ks depends on dwell times and run
lengths, equation 2.3 was plotted for varying dwell times (τrb) and run lengths
(Lrb) in the presence of roadblocks (figure 2.10). To avoid mistakes, different
variable names were used (equation 2.4)
ks =
L− − Lrb
τrb ·L− − τ− ·Lrb
(2.4)
The unperturbed dwell time τ− and run length L− were kept constant at the values
measured in BRB20 (see table 2.4). In order to further reduce the complexity, in
a first step, the dependence of ks on τrb alone was plotted, keeping Lrb constant at
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Figure 2.10: Dependency of ks on the dwell time and run length in the
presence of roadblocks - Plots were calculated from equation 2.4. The variables
τ− and L− of that equation were kept constant at 2 s and 1.4 µm, respectively. (A)
Two dimensional plot of ks depending on τrb at a constant value of Lrb = 0.37 µm.
(B) Plot of ks depending on Lrb at a constant value of τrb = 0.86 s. Red lines in
(a) and (b) correspond to the limits, where the respective function goes to infinity.
(C) Contour plot of ks depending on τrb and Lrb. The value of ks is indicated by
color coding shown in the color scale bar. Additionally, negative values are shown
in white, while values larger than the maximum of the color scale are shown in
black. Dashed lines indicate example lines where ks stays constant (D) Surface plot
of ks depending on τrb and Lrb. The purple lines represent the two dimensional
plots shown in (A) and (B). The color coding of (D) is the same as in C. To better
illustrate the shape of the surface, a grid is superimposed with gray lines parallel to
the τrb axis and black lines parallel to the Lrb axis. The value that was calculated
for ks is indicated by a green circle, the value for ks that was measured directly is
indicated by a red circle.
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the value of L+ (figure 2.10A). In this plot, ks depends hyperbolically on τrb. The
lower limit for τrb, where ks goes to infinity can be calculated from equation 2.4.
The denominator of this equation becomes zero when the speed with roadblocks
is the same as the speed without roadblocks:
L−
τ−
=
Lrb
τrb
(2.5)
and therefore
lim τrb =
τ− ·Lrb
L−
=
Lrb
v̄−
. (2.6)
Since Lrb was kept constant at the value of L+, the lower limit for τrb in figure
2.10A is: lim τrb =
2 s · 0.37 µm
1.4 µm
= 0.53 s This lower limit for τrb does make sense,
because no speed change would mean that the motors would detach immediately
when encountering an obstacle and thus ks would become infinitely large. On the
other hand, a large τrb can always be explained by a very low dissociation constant
in the stopping phase. Analogous, the dependence of ks on Lrb was plotted at
constant τrb (figure 2.10B). Interestingly, Lrb is restricted to a small range between
0 and L−. While the lower limit for Lrb is trivial, the upper limit requires some
attention: Only running phases contribute to Lrb, therefore a Lrb larger than L−
could only be explained if roadblocks would increase the processivity of kinesin-1
in the running phases. However, such an influence between the stopping and the
running phase was excluded in the assumptions that the calculation of ks is based
on.
In order to further illustrate how ks is connected to τrb and Lrb, the dependence
of ks on both τrb and Lrb was plotted in a contour plot (figure 2.10C) and 3D surface
plot (figure 2.10D). The limits that were just discussed show up as distinctive
features in the contour plot: The upper limit for Lrb is the upper limit of the graph
at 1.4 µm, where ks becomes zero. The lower Limit for τrb is the diagonal line
described by equation 2.6, below which ks becomes negative (within the allowed
range for L+). This gives an area of allowed values for τrb and Lrb. Interestingly,
within this area, ks increases with Lrb when τrb is smaller than τ− and decreases
with Lrb when τrb is greater than τ−. This can be seen well in the surface plot
(figure 2.10D), comparing the blue and red areas of the 3D plot. The reason for
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this behavior is that when τrb is less than τ− (which is the case for all results shown
in table 2.4), the effect of Lrb on the denominator of equation 2.4 is predominant
and thus ks increases hyperbolically with increasing Lrb. On the other hand,
when τrb is greater than τ−, the effect of τrb on the numerator of equation 2.4
predominates and thus ks decreases with increasing Lrb.
Another intriguing feature is that the lines where ks remains constant (dashed
lines in figure 2.10C) move outward radially from the point where Lrb equals
L− and τrb equals τ−. Since ks is probably a constant that is characteristic for
each motor protein, it should be independent of roadblock density while Lrb and
τrb are not. Therefore, it is reasonable to assume, that the distance from this
central point along these lines correlates somehow with the roadblock density.
The corresponding change in Lrb and τrb then reflects a decrease in average motor
speed with increasing roadblock density.
Dissociation state: Comparing the results obtained for different salt concen-
trations (table 2.4 BRB20 and BRB80) shows that run length and dwell time
without obstacles are reduced about twofold in higher salt concentrations and
consequently the off rate is increased. This is consistent with previously published
results73,127. The same effect is observed in the presence of roadblocks (k+ is
increased twofold in BRB80). Consequently, ks is also increased roughly twofold.
This indicates that salt concentration affects dissociation similarly in the stopped
phases and in the running phases. Therefore, it can be hypothesized, that the
state the motor is in when it dissociates is similar in the running- and in the
stopping phase. This ”dissociation state” is probably a single headed bound state.
This hypothesis does make sense because kinesin-1 is not affected by an obstacle
until the forward head fails to attach to the next binding site. By that time,
the forward head is already detached from the microtubule resulting in a single
headed bound stopping state, unless the free head rebinds. The hypothesis is
also supported by the fact that the ks of 3.6 s
−1 measured in BRB80 agrees very
well with the microtubule dissociation rate measured for single headed kinesin-1
heterodimers by Hancock and Howard 70 .
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Implications for kinesin-1’s stepping mechanism: Kinesin-1 waited in the
stopping state for a characteristic stopping time of 0.5 s before detaching from
the microtubule. Under the same conditions (BRB20) the average time per step
was ≈ 12 ms (8.2 nm/700 nm/s). Assuming that kinesin-1 stops with its trailing
head bound (see the considerations on the dissociation state above), this indicates
that leading head attachment must increase trailing head detachment by at least
a factor of ≈ 40. Recently, experiments using elongated neck linkers and force
feedback optical trapping have shown that such an increase in trailing head
detachment can be caused by internal strain between the motor heads mediated
by the neck linker63.
Bypassing roadblocks: Interestingly, about half of the stopping kinesin-1
molecules were able to overcome obstacles eventually (representative events shown
by the pausing kinesin-1s in figure 2.2C and figure 2.3). This behavior is not
included in the proposed model for the stopping mechanism, yet. One way
to explain this behavior is that kinesin-1 molecules are able to pass obstacles
during their processive runs. This would be possible if obstacles and kinesin-1
molecules did not occupy the same binding sites on the polymerized tubulin dimers.
Molecular flexibility could then allow motors to pass obstacles — their stepping
probability still being sufficiently reduced to account for the observed non-running
phases. Alternatively, the motors could detach from the microtubule, but instead
of going into solution, they could diffuse two-dimensionally along the microtubule
lattice and rebind adjacent to — or past — the obstacle. A similar diffusion has
recently been identified for various members of the kinesin superfamily, namely
kinesin-13139 kinesin-8140 and kinesin-5141. This second mechanism for overcoming
obstacles is supported by the fact that the dissociation rate measured for stopping
events (kstop, see figure 2.6A) was almost identical to the rate with which kinesin-1
overcomes obstacles (kcontinue, see figure 2.6B). The fact that kstop and kcontinue are
almost identical is also the reason, why ignoring the fact that kinesin-1 overcomes
obstacles in the model still resulted in a correct prediction of ks.
The multi-motor case: In a gliding assay, where each microtubule is trans-
ported by many kinesin-1 motors, obstacles on the microtubule lattice will cause
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some motors to stall. This stalling causes a significantly increased drag force
during the period where the motors remain attached and provides an explanation
for the slow-down of gliding microtubules (see also figure 2.7 for a schematic
drawing). This is also supported by the fact that occasional stopping and jerky
movement of short microtubules was observed in gliding assays with low kinesin-1
density (data not shown). However, usually high kinesin-1 densities were used
and therefore the speeds measured for figures 2.8 and 2.9 were uniform, i.e. did
not represent the averages of fast movement and pauses. It is therefore concluded,
that the observed deceleration of obstacle-laden microtubules in gliding assays is
caused by an obstruction of kinesin-1 pathways on the microtubule lattice rather
than by ”frictional” cargo-surface interactions.
Conclusions: Being a motor protein responsible for fast cargo transport, kinesin-1’s
behavior at roadblocks is uniquely optimized for operating on highly crowded
microtubules — despite its seemingly inflexible motor mechanism (see section 1.1).
It is more efficient to wait when an obstacle is transient (just like being stuck in
stop-and-go traffic with a car). In contrast, when an obstacle blocks the path for
a long time (like a construction site) the destination will be reached quicker by
dissociating from the microtubule and reattaching to another microtubule or a dif-
ferent protofilament on the same microtubule (taking a detour). Releasing quickly
when blocked by an obstacle also improves the efficiency of transport when more
than one motor is attached to the cargo, because a non-moving motor will slow
down transport in contrast to a detaching motor (see below). The characteristic
stopping time kstop of kinesin-1 probably represents the optimal compromise be-
tween waiting at an obstacle and detaching in order to find a clear path and avoid
to hinder other motors. Additionally, the obstacles which kinesin-1 encounters in
vivo have probably been adapted by evolution to complement the functions of the
motor protein. For example, it has been shown that the microtubule associated
proteins MAP2c and Tau have no effect on kinesin-1’s dwell time or run length
when associated regularly to microtubules142. In contrast, Tau can form dense
patches on microtubules at higher concentrations143,144 which cause kinesin-1 to
stop and to detach133. This behavior was hypothesized to be a mechanism to
control the targeting of kinesin-1’s cargo, but might also be related to the role of
46
2.3 Discussion
Tau in Alzheimers disease. As discussed before, a similar behavior of kinesin-1
at roadblocks was observed when the obstacle was another kinesin-1 motor134,135.
This indicates, that the impact of microtubule decoration on kinesin-1 activity
most likely strongly depends on whether a microtubule associated protein and
kinesin-1 occupy a different- or the same binding site on the microtubule lattice.
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A novel method for molecular
detection
Beyond an improved understanding of the interaction between kinesin-1 and
cargo-laden microtubules, it can be imagined that microtubule slow-down can, in
return, be utilized for a novel molecular detection scheme. Cargo density on the
microtubule lattice translates into a predictable change of gliding speed. Therefore,
it is possible to infer the concentration of such cargo from speed measurements.
This effect was used develop a protein detection system based on the roadblock
effect.
3.1 Detection of streptavidin and anti-rhodamine
antibodies
The data presented in section 2.2 can already be seen as the detection of strep-
tavidin from solution. Additionally, it was observed that non-biotinylated mi-
crotubules were not affected by streptavidin. The fact that one population of
microtubules was slowed down, while the other one was unaffected led to the
assumption that multiple proteins could be detected simultaneously without af-
fecting each other, provided that several microtubule populations — each binding
a different protein — were used (unspecific influences could be eliminated by a
control population of microtubules). To demonstrate this, two distinct micro-
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Microtubule
binding protein X
Microtubule
binding protein Y
Protein YProtein X Kinesin-1 Microtubule
speed
Figure 3.1: Microtubule based detection assay - The speed of protein-coated
microtubules gliding on a kinesin-1 surface is determined by the density of the
coating protein and can be used for differential detection.
tubule populations (fluorescein labeled microtubules with a biotinylation ratio
of 0.25 and non-biotinylated rhodamine labeled microtubules) were used in one
gliding assay (see figure 3.1). This microtubule mixture was then incubated with
10 µM non-fluorescent streptavidin and/or 10 nM non-fluorescent anti-rhodamine
antibodies.
Time-lapse fluorescence images of typical microtubules of each population are
shown in Figure 3.2A together with the corresponding speed measurements in
Figure 3.2B. Before incubation with streptavidin or rhodamine antibodies, both
populations moved with similar speeds. After incubation with streptavidin, green
microtubules slowed down to about 40 % of their original speed while the speed
of red microtubules remained unaffected. Similarly, incubation with rhodamine
antibodies slowed down red microtubules to about 60 % of their original speed
without affecting green microtubules. After incubation with both reagents at the
same time, both microtubule populations were slowed down.
These results show that a novel, highly-sensitive mechanism for parallel molec-
ular detection becomes possible when several microtubule populations (that
specifically bind the molecules or particles of interest) are used. Measuring their
speeds after incubation with a test sample and relating the obtained values to
an inert control population would then allow a quantitative inference about the
molecular composition of the test solution.
50
3.1 Detection of streptavidin and anti-rhodamine antibodies
0.8
0.6
0.4
0.2
0.0
m
ic
ro
tu
bu
le
 s
pe
ed
 / 
um
 s
-1
-SA  -AB +SA  -AB -SA  +AB +SA +AB
flu
or
es
ce
in
-la
be
le
d,
 b
io
tin
yl
at
ed
 m
ic
ro
tu
bu
le
s
rh
od
am
in
e-
la
be
le
d 
m
ic
ro
tu
bu
le
s
A
B
0 s
3.5 s
7 s
10.5 s
14 s
-SA  -AB +SA  -AB -SA  +AB +SA  +AB
10 µm
Figure 3.2: Simultaneous detection of streptavidin and anti-rhodamine
antibodies - Selective slow-down of biotinylated fluorescein labeled (green) or
rhodamine labeled (red) microtubule populations incubated with combinations
of non-fluorescent streptavidin (SA) and rhodamine antibodies (AB) in the same
gliding assay. (A) Time-lapse fluorescence images of both fluorescence channels upon
the addition of SA and/or AB. The paths traveled by the microtubules in a given
time period are indicated by white crosses. (B) Average speeds of the individual
microtubule population. Speeds are given as averages ± standard deviations of 20
microtubules.
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3.2 A generalized detection method
So far the proposed detection mechanism has been shown to detect the interactions
of small molecules with proteins. In order to detect a wide variety of analytes
the use of analyte-specific recognition probes linked to the microtubule lattice is
necessary. Such probes could be antigen binding fragments of antibodies (FABs)
or aptamers, as specific recognition probe. However, because FABs are comparable
in size to streptavidin (∼ 50 kDa), one might expect them to act as roadblocks
themselves. Even aptamers (∼ 10 kDa) — while much smaller than FABs — are
still a lot larger than the rhodamine or biotin modifications (< 1 kDa) that were
tested to have no effect on microtubule speed. Therefore, it was tested, whether
binding of an analyte to a relatively large recognition probe can still be detected
as a slow-down of gliding microtubules.
Detecting binding of an analyte to a ”large” recognition
probe
Microtubule
Kinesin-1
anti-streptavidin
antibody
Streptavidin
Biotin
Figure 3.3: Testing the versatility of the proposed detection - Streptavidin
coated microtubules were incubated with anti-streptavidin antibodies to test whether
this additional binding could be detected by an additional slow-down effect.
The principal feasibility of a detection using a comparatively large recognition
probe needs to be investigated. To do this, it was tested if the binding of
fluorescein-conjugated, polyclonal anti-streptavidin antibody (i.e. the ”analyte”)
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to streptavidin-coated microtubules would lead to a further, detectable slow-down
(Figure 3.3).
The initial speed of biotinylated gliding microtubules (figure 3.4, red bars)
was decreased by 30 % after streptavidin coating (figure 3.4, channel 1 and
2, green bars), while microtubules incubated with a control solution without
streptavidin remained unaffected (figure 3.4, channel 3, green bar). Subsequent
incubation with anti-streptavidin antibody (100 nM, 10 min) decreased the speed
significantly (p value  0.01) by another 70 % (figure 3.4, channel 1, blue bar).
The successful binding of anti-streptavidin antibody to microtubules was confirmed
by fluorescence images taken in the fluorescein channel (data not shown).
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Figure 3.4: Detecting anti-streptavidin antibodies using streptavidin-
coated microtubules. - Gliding speeds of microtubules in three independent flow
channels. The speeds of representative microtubules were measured in each channel
before treatment (red bars), after incubation with or without streptavidin (green
bars) and after incubation with or without anti-streptavidin antibody (blue bars).
Speeds are given as averages ± standard deviations of 20 microtubules.
Control populations of biotinylated microtubules, that were (i) coated with
streptavidin and incubated with a control solution without anti-streptavidin
antibody (figure 3.4, channel 2, blue bar) or (ii) not coated with streptavidin
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and incubated with anti-streptavidin antibody (Figure 3.4, channel 3, blue bar),
remained unaffected. This shows that detection of an analyte which is linked to
microtubules via a molecule that is comparable in size to a FAB is possible.
Using Aptamers as recognition probes
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Figure 3.5: Covalently linking aptamers to microtubules - (A) The chemical
cross linking reaction: 4-hydrazidoterephtaloyl groups and 4-formylbenzoyl groups
of modified microtubules and aptamers form a stable bis-aryl hydrazide hydrazone
bond. (B) Sequence and predicted structure of the aptamer (adapted from Wiegand
et al. 145). (C) Schematic drawing of a microtubule covalently coated with aptamers.
Aptamers would provide an even smaller probe, that are just as flexible as FABs
in specifically recognizing the target analyte. Therefore, the possibility to use
aptamers for microtubule based molecular detection was explored. In a preliminary
experiment, a published sequence of a well studied anti-human immunoglobulin
54
3.2 A generalized detection method
E aptamer was used145. This oligonuleotide was ordered with a fluorescent label
at the 3’ and a primary amine group at the 5’ end. This aptamer was covalent
ly attachment to microtubules using a protein conjugation toolkit based on
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Figure 3.6: Aptamers covalently
linked to microtubules - Fluorescence im-
ages of rhodamine labeled microtubules after
incubation with fluorescein labeled aptamers
imaged in the rhodamine (left) and fluores-
cein (right) channels. Microtubules were
grown with SHTH-tubulin (top) or without
SHTH-tubulin (bottom), respectively.
Succinimidyl 4-hydrazidoterephtalate
hydrochloride (SHTH) and Succin-
imidyl 4-formylbenzoate (SFB). In
a first step, these two reagents were
linked to primary amine groups of
tubulin and aptamers via their suc-
cinimidyl groups in separate reac-
tions. Afterwards, the SFB-modified
aptamers could be linked to micro-
tubules grown with SHTH labeled
tubulin (figure 3.5).
Rhodamine and SHTH labeled mi-
crotubules were incubated with SFB
and fluorescein labeled aptamers for
48 h. Excess aptamer was removed
by applying the microtubules to a
gliding assay and subsequent washing.
Successful specific aptamer conjuga-
tion was confirmed by fluorescence
microscopy (figure 3.6): Microtubules
grown with SHTH labeled tubulin
could be detected both in the rho-
damine and the fluorescein channel,
while control microtubules grown without SHTH labeled tubulin did not show
any signal in the fluorescein channel. However, the labeling efficiency was still
far below what was expected for the SHTH labeling ratio (50 %) used. The low
density of aptamers measured by the flurescence intensity is also reflected by the
fact that there was no significant speed difference between aptamer labeled- and
control microtubules (0.65± 0.025 µm/s and 0.64± 0.051 µm/s, respectively; the
speeds given are the averages ± standard deviations of 20 microtubules).
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One possible reason for the low labeling efficiency is degradation of aptamers.
SFB and the fluorescent label are on opposite sides of the oligonucleotide. There-
fore, only intact aptamers will contribute to the fluorescent signal. Such degrada-
tion was confirmed with agarose gels of aptamers incubated over extended periods
of time in conjugation buffer (data not shown). This might be alleviated by optimiz-
ing incubation times, using the more reactive Succinimidyl 6-hydrazinonicotinate
acetone hydrazone (SANH) and adding EDTA to the reaction buffer (lowering
the activity of nucleases).
3.3 Discussion
The slow-down of microtubules in gliding assays was characterized as a function
of streptavidin concentration on the microtubule lattice. On the one hand, this
improved understanding of motor interactions with cargo-laden microtubules
can be used for nanotechnological applications, to optimize cargo density on
microtubules without compromising gliding speeds. On the other hand (even more
importantly), a novel molecular detection scheme based on this slow-down effect
was demonstrated. For distinguishable fluorescence detection different microtubule
populations might be labeled with a number of different fluorophores (possibly
using fluorescently labeled aptamers). Upscaling to a high number of different
microtubule populations could be achieved by patterns of different fluorophores
in a bar-code like fashion146.
Versatile recognition probes are compatible with the detection scheme:
It was shown that it is possible to detect an additional slow-down caused by
an analyte which is linked to microtubules via a molecule that is comparable
in size to a FAB. This additional slow-down indicates that the roadblock effect
described in chapter 2 depends on the size of the obstacle. This seems unintuitive
at first, since stopping at a roadblock should not depend on the size of the obstacle,
once it is big enough to stop kinesin-1. However, kinesin-1’s ability to overcome
roadblocks (as observed in the data related to figure 2.2) might very well depend
on the size of the obstacles (just like it is easier to drive a car around a tree than
around a house). This size-dependent roadblock effect is interesting and will be
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the subject of further studies. These results indicate that versatile recognition
probes to the molecules of interest could be provided by FABs or aptamers147
that are chemically cross linked to the lattices of microtubules. This flexibility
provides a crucial advantage of the method proposed here over earlier reports
where the gliding speed of actin filaments was used for the detection of mercuric
ions148. There, the slow-down mechanism was based on the covalent reaction of
mercuric ions with the motor proteins themselves.
Detection limit: The detection limit of the proposed detection scheme can
be estimated by the following considerations: For the case of streptavidin de-
tection on biotinylated microtubules a significant (p = 0.04, Student’s t-test)
slow-down of about 5 % (compared to the unbiotinylated control) is observed
with presumably one streptavidin molecule bound to every hundredth tubulin
dimer (lowest biotinylation ratio of 0.01 in figure 2.8B). Considering a microtubule
geometry with 13 protofilaments and a dimer repetition length of 8 nm, this corre-
sponds to a maximum of 16 streptavidin molecules per µm length of microtubule.
Therefore, a total of about 600 molecules attached to 20 microtubules with an
average length of 2 µm should suffice to detect significant speed differences. The
detection sensitivity in terms of the lowest detectable concentration is determined
by the dissociation constant of the recognition probe and the analyte. FABs and
aptamers usually have dissociation constants in the range of nM which means that
enough molecules for detection can be collected either (i) out of a very diluted
large sample (limited by the dissociation constant of the FAB or aptamer used
for binding) or (ii) out of a relatively concentrated, very small sample. Note,
that the detection volume is only limited by the volume that microtubules can
be immersed in experimentally. Therefore, it is conceivable to use the proposed
method for the detection of proteins from single cells.
Conclusions: Very recently, a ”smart dust” biosensor based on a microtubule
gliding assay was demonstrated109,110. This prototype sensor minimizes the
classical double antibody sandwich assay, using microtubule based transport
to circumvent elaborate purification steps (see page 21). The main difference
between that approach and the detection scheme presented here is that the
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biosensor requires two antibodies against different binding sites of the analyte. In
addition, the way the detection is implemented in that sensor is optimized more
for easy and fast detection than for sensitive detection from very small sample
volumes. Consequently, it is proposed to exploit the fact that the detection method
proposed here requires less components and is therefore easier minimized. This
could lead to a detection device which is optimized for highly sensitive label-free
detection out of very small samples. Other highly sensitive label-free methods
for the detection of proteins from solution based on carbon nanotubes149,150
microcantilevers151 and surface plasmon resonance152 have been described in
the literature. However, unlike these methods, the molecular detection scheme
proposed here could be extended to the sorting and concentrating of biomolecules
in highly integrated devices. Different microtubule populations walking along
elongated tracks could be separated either by their speed (due to different cargo
densities and sizes) or by their fluorescence (possibly bar-coded) color. Such a
separation of gliding microtubules based on their color could be achieved by steering
microtubules gliding in microfabricated channels into respective reservoirs by an
electric current19,153 or hydrodynamic flow25. In these reservoirs, microtubules
could be concentrated by an appropriate shape of the collector20,154 for further
analysis of the analyte.
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Towards temporal motility
control
Motor proteins such as kinesin-1 have been successfully implemented into synthetic
environments. Basic tasks like sorting, transport and detection have been suc-
cessfully demonstrated19,22,29,100,101,103–110,113,155 (see also chapter 3). However, the
lack of precise and flexible spatio-temporal control mechanisms for motor proteins
has seriously hampered their application in more complex tasks like nano-assembly
lines. In this chapter, two schemes that could provide next-generation means of
temporal control over the kinesin-1-microtubule transport system are going to be
introduced.
4.1 Switchable roadblocks
The ability to start and stop the movement of single microtubules by external
signals would be a milestone achievement towards the application of microtubules
as controlled nano-transport devices. For example, this starting and stopping
could be used to improve the loading and unloading of cargo29,106 or increase
the efficiency of chemical reactions acting on cargo transported by microtubules
in nano-assembly-lines. The roadblock effect described in chapter 2 appears
to depend on the size of the obstacle (as discussed in section 3.3). Therefore,
roadblocks with switchable size could provide such a means of temporal control.
For example, poly(N-isopropyl acrylamide) (PNIPAM) is a polymer that switches
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Figure 4.1: Thermoresponsive polymers on microtubules - PNIPAM
switches between a collapsed (left) state at temperatures above - and an extended
state (right) at temperatures below its lower critical solution temperature. Micro-
tubules coated with these polymers will have obstacles of switchable size on their
lattice (bottom)
between an extended and a collapsed state depending on whether the temperature
is above or below its lower critical solution temperature (figure 4.1 top). This
polymer is therefore a prime candidate as size-switchable roadblock.
Rhodamine labeled microtubules were coated with a biotinylated version of
PNIPAM (figure 4.1 bottom; average molecular weight: 40 kDa, kindly provided
by our collaborators Dirk Kuckling and Wolfgang Birnbaum, TU-Dresden, now
Universität Paderborn) using streptavidin as linker molecule. These microtubules
were then observed at different temperatures in a gliding assay with very low
kinesin-1 density (estimated to be ∼ 2 motors per 10 µm2 by the length of the
shortest gliding microtubules) on a hydrophobic surface. Fluorescein labeled, non-
biotinylated control microtubules in the same channel were observed simultaneously
by switching filters in-between each image of the timelapse movies taken. At
the end of the experiment, most microtubules were removed by rigorous washing
at 20˚C and fresh, rhodamine labeled control microtubules, coated only with
streptavidin, were added. Microtubule positions were tracked using FIESTA
(rhodamine labeled microtubules) or by hand (fluorescein labeled microtubules).
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Figure 4.2: Motility switching of PNIPAM-coated microtubules - Switch-
ing behavior of microtubules gliding on kinesin-1-coated surfaces. Microtubules were
either coated with streptavidin and PNIPAM (PNIPAM + SA), coated only with
streptavidin (SA only) or not biotinylated and thus coated with neither streptavidin
nor PNIPAM (Non-biotinylated). (A) Movement-indicating fluorescence images.
Each image is combined from the first frame of a movie in green with the maximum
projection in red and the last frame in blue. Thus non-moving objects appear white,
while moving objects are colorful. Microtubules that were only partially stuck to the
surface are highlighted with stars, while microtubules moving with directed motion
are indicated with arrows. (B) Time-Distance plots of one example microtubule
of each population observed while switching between 35˚C (orange background),
25˚C (blue background) and back. Insets show drawings of microtubules, decorated
with collapsed (35˚C) or extended (25˚C) PNIPAM, gliding on a kinesin-1-coated
surface. (C) Average speeds of the different microtubule populations at 35˚C and
20˚C (weighted mean ± standard deviation; n = 32 (PNIPAM-MT), 24 (SA only)
and 33 (Non-biotinylated), respectively).
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At temperatures above the lower critical solution temperature of PNIPAM
(35˚C, collapsed state of PNIPAM), almost all streptavidin-coated microtubules
were stuck to the surface (98 %). This sticking was only observed for hydrophobic
surfaces and only after heating to 35˚C at least once. In contrast, nonbiotiny-
lated control microtubules were gliding at increased speed at 35˚C compared
to 20˚C as expected for any biomolecular reaction (100 % of all microtubules
were gliding). Upon switching to lower temperatures (20˚C, extended state of
PNIPAM), PNIPAM-coated microtubules were released either completely into
solution (57 %), gliding on the kinesin-1-coated surface (29 %) or remained par-
tially stuck to the surface (14 %). Control microtubules, coated with streptavidin
only, remained stuck to the surface (99 %). This switching behavior can be seen
qualitatively in movement-indicating fluorescence images that show movement
in color and stopping microtubules in white (figure 4.2A). Time-Distance plots
of one example microtubule of each population further illustrate that behavior
(figure 4.2B): The non-biotinylated microtubule glides with homogeneous speed
both at 35˚C and 20˚C. Note the decrease in speed upon switching from high to
low temperature (blue line). The microtubule that was coated with streptavidin
only, moves neither at high nor at low temperatures (green line). The appar-
ent displacement during temperature-switching is caused by thermal drift. The
microtubule coated with both streptavidin and PNIPAM is released from the
surface approximately 20 s after the switch to low temperature. It then glides with
varying speeds until the temperature is increased again (red line). This behavior
was quantified by measuring the average frame to frame speeds of more than 20
microtubules of each population during the high and low temperature periods
(figure 4.2C). The apparent average frame to frame speeds of 11.4± 2.4 nm/s and
15.2± 3.6 nm/s of microtubules coated only with streptavidin can be attributed
mainly to tracking inaccuracies. Non-biotinylated control microtubules were
gliding with 569± 45 nm/s at 20˚C and 1210± 34 nm/s at 35˚C which are the
expected speeds for kinesin-1-propelled microtubules at these temperatures. At
35˚C microtubules coated with streptavidin and PNIPAM showed the same, low
average speed (13.5± 3.1 nm/s) as microtubules coated with streptavidin only.
However at 20˚C these microtubules were released and started diffusing and/or
gliding along the surface. The comparatively low average speed and high standard
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deviation (51.2± 12.8 nm/s) reflect the inhomogeneity of the observed movement.
This inhomogeneity comes from averaging over the three populations described
above: released(57 %), gliding (29 %) and stuck (14 %) microtubules.
Discussion
In order to improve the release of streptavidin- and PNIPAM coated microtubules
from the surface without losing them into solution, the nature of the sticking
needs to be studied in more detail. Stopping of these microtubules occurs when
the polymer attached to the microtubules is collapsed (at high temperatures).
Additionally, the stopping occurred also for microtubules coated only with strep-
tavidin and in particular, only on hydrophobic surfaces. Therefore, it is likely
that this sticking is caused by interactions of streptavidin with the hydrophobic
surface. The release at 20˚C is then probably caused by PNIPAM chains swelling
and pushing the stuck microtubules off the surface. Whether these microtubules
are then released completely into solution or continue to glide possibly depends
on the length of the PNIPAM chains.
Despite requiring further optimization to increase the efficiency of switching,
these results are highly promising. Other advances towards temporal motility
control of microtubules have been made using photocaged compounds in solution.
These approaches have achieved activation120 or deactivation27 of kinesin-1. How-
ever, Tucker et al. 120 use photocaged ATP making their approach unusable in
more complex systems where other processes require ATP. On the other hand,
the photocaged inhibitor used by Nomura et al. 27 does not achieve complete
stopping of microtubules. A third approach uses PNIPAM-coated surfaces26. In
this setup, PNIPAM prohibits microtubule binding to surface-attached kinesin-1
in its swollen state and allows gliding in the collapsed state. This approach
allows efficient removal of microtubules from a surface. However, with this system
microtubules are released into solution, not stopped on the surface, thus not
allowing to stop microtubules at a specific location and restart their motility
later. This approach could be combined with recent experiments and simulations
showing that it is possible to use light-to-heat converting layers to locally heat
surfaces with great temporal and spacial resolution30. Therefore, the starting and
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stopping of microtubules on the surface by an external signal shown in this section
represents a significant advancement towards the nanotechnological application
of the kinesin-1-microtubule transport system and justifies to put further efforts
into optimizing this system.
4.2 Towards photo-switchable kinesin-1
A photo-switchable kinesin-1 would be a very flexible tool to achieve spatio-
temporal control over single molecules of this motor protein. This is highly
desirable for advanced nanotechnological applications such as nano-assembly
lines that require extremely detailed control. Additionally, such a switchable
motor could be used biophysical studies analyzing, for example, the cooperative
behavior of kinesin-1 and dynein motors. Covalently linking an inhibitor directly
to kinesin-1’s motor head is an interesting approach in this direction. However, in
order to not permanently deactivate the protein, this inhibitor would need to be
switchable. Ideally, this switching would be controlled by light to obtain optimal
spacial and temporal resolution. Great advances towards optical control of protein
activity have been made by introducing photochromic residues into polypeptide
chains156. Photochromic substances such as spirobenzopyrans and azobenzenes
reversibly change their absorption spectra, their structure and their polarity upon
light irradiation. These property changes, when applied in the right place, can be
used to create photo-switchable proteins. This has been successfully shown for
a short DNA-binding polypeptide157, an ionotropic glutamate receptor31 and a
chaperone158.
Approach
A photo-switchable kinesin-1 needs some kind of photo-responsive element. One
such group which is widely used is azobenzene, a chemical compound that switches
from cis- to trans state upon irradiation with light of 380 nm wavelength (figure
4.3A). While the energy transported by a photon of this wavelength is sufficient
for substantial structural changes, it is still close enough to visible light that it
will not cause significant damage to biological systems. Azobenzene has been
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previously used successfully to induce structural changes in an alpha helix and
to create photo-switchable proteins31,157,158. To provide on-and-off switching
functionality, a linker containing an azobenzene group shall be used to tether an
inhibitor (in this case AMPPNP) to its binding pocket on the protein (see figure
AMPPNP
Kinesin-1 motor head
switchable
tether
N N
N Nh ν.
trans cis
Azobenzene
h ν.
A
B
Figure 4.3: Schematic drawing of a
photo-switchable kinesin-1 - (A) Azo-
benzene in trans- (dark state) and cis-
conformation (bright state) . (B) Sketch
of AMPPNP, a slowly hydrolyzable ATP
analog linked to the kinesin-1 motor head
via a photo-switchable tether.
4.3 B). This linker needs to be de-
signed such, that its sterical confor-
mation allows binding of the tethered
AMPPNP residue to the nucleotide
binding pocket in one photo-state and
prohibits it in the other, thus switch-
ing the protein on and off by light. A
similar approach was used by Volgraf
et al. to create a photo-switchable
glutamate receptor31.
Thiol reactive chemistry shall be
used to specifically attach the linker
to the target site on the kinesin-1
molecule. To avoid unwanted side re-
actions, all solvent accessible native
cysteine residues need to be replaced
with other amino acids to create a
cysteine-light kinesin-175. Subsequently, a cysteine residue shall be introduced at
the site that is to be modified.
The feasibility of this approach was confirmed by (i) testing whether ATP
modified with a tether still binds to kinesin-1 and activates microtubule binding
and (ii) modeling the switching of AMPPNP tethered to kinesin-1’s nucleotide
binding pocket via a photo-switchable tether.
Modified ATP activates kinesin-1
The ability of kinesin-1 to bind a tethered ATP analog and still be active was
tested in a gliding assay with Alexa 647 ATP as a model ATP analog. Alexa
Fluor 647 ATP has a fluorophore tethered to the 2’ or 3’ hydroxyl group of ATP’s
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Figure 4.4: Alexa Fluor 647 ATP - Parts of the ATP molecules which appear
to be exposed to solution in the kinesin-1 crystal structure are marked in red. The
fluorophore is marked in blue and the extension linking the fluorophore and the
ATP molecule is marked green. The structure of Alexa Fluor 647 has not been
published and is therefore represented by an ellipse.
ribose moiety (see figure 4.4). According to kinesin-1’s crystal structure, these
hydroxyl groups are exposed to solution.
In the presence of 1- or 2 mM of this ATP analog, microtubules obtained a
gliding speed of 12± 3 nm/s, indicating that both concentrations are saturating
and that the residual speed is not caused by contaminations with unmodified ATP.
In the presence of both 2 mM ATP and 2 mM Alexa ATP, microtubule gliding
speed was 400± 46 nm/s while microtubule speed in the presence of 2 mM ATP
alone was 500± 54 nm/s. These results indicate that an ATP analog which has a
tether attached to it can still bind to kinesin-1 (albeit with a lower affinity than
ATP), but is hydrolyzed at a greatly reduced rate and effectively blocks the ATP
binding pocket.
Homology modelling
The only available kinesin-1 crystal structures are rat and human kinesin-1. There-
fore, the sequence of drosophila kinesin-1 was fitted into the known structure
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(figure 4.5A) of human kinesin-1 by homology modeling.
D
A B
C
Figure 4.5: Homology modelling - Homology modeling of drosophila kinesin-1.
(A) Crystal structure of human kinesin-1 used as template (PDB id: 1MKJ159). (B)
Drosophila kinesin-1 modeled by SwissModel (DRMSD = 1.07 Å). The backbones
of sequence inserts which were not matched by the human structure are shown
in red (upper left and lower right corners). (C) Modeled structure of drosophila
kinesin-1 after refinement. (D) The modeled structure containing ADP. (A, C, D)
The nucleotide binding pockets are indicated by white ovals. (C, D) The position
of the introduced cysteine residue is marked with arrows.
The sequence of the motor head of drosophila kinesin-1 was aligned to the
sequence attached to the structure of human kinesin-1 (PDB id: 1MKJ) using the
SwissPDBViewer (table 4.1). The total sequence identity between both sructures
was 77 %. The drosophila sequence was already modified close to the ATP binding
pocket, replacing a serine residue with cysteine (Mutation: S109C). This mutation
will also have to be introduced experimentally into the kinesin-1 vector prior to
67
4. TOWARDS TEMPORAL MOTILITY CONTROL
Table 4.1: Sequence alignment - Sequence alignment of the drosophila kinesin-1
motor head (Drosophila) with the structure of human kinesin-1 (1MKJ)159. The
total sequence identity was 77 %. The quality of alignment is indicated by (*) for a
perfect match, (.) for similar amino acids and ( ) for no match. The drosophila
sequence already contains a mutation replacing a serine residue close to the ATP
binding pocket with cysteine (Mutation: S109C shown in red).
Drosophila 1 MSAEREIPAE DSIKVVCRFR PLNDSEEKAG SKFVVKFPNN VEENCISIAG
1MKJ 2 ADLAE CNIKVMCRFR PLNESEVNRG DKYIAKF--- QGEDTVVIAS
Quality ** .***.**** ***.** . * *.. ** *. . **.
Drosophila 51 KVYLFDKVFK PNASQEKVYN EAAKSIVTDV LAGYNGTIFA YGQTSSGKTH
1MKJ 44 KPYAFDRVFQ SSTSQEQVYN DCAKKIVKDV LEGYNGTIFA YGQTSSGKTH
Quality * * **.** ...*** *** . ** ** ** * ******** **********
Drosophila 101 TMEGVIGDCV KQGIIPRIVN DIFNHIYAME VNLEFHIKVS YYEIYMDKIR
1MKJ 94 TMEGKLHDPE GMGIIPRIVQ DIFNYIYSMD ENLEFHIKVS YFEIYLDKIR
Quality **** . * ******* **** **.*. ********* *.***.****
Drosophila 151 DLLDVSKVNL SVHEDKNRVP YVKGATERFV SSPEDVFEVI EEGKSNRHIA
1MKJ 144 DLLDVSKTNL SVHEDKNRVP YVKGCTERFV CSPDEVMDTI DEGKSNRHVA
Quality ******* ** ********** **** ***** **..* . * .*******.*
Drosophila 201 VTNMNEHSSR SHSVFLINVK QENLENQKKL SGKLYLVDLA GSEKVSKTGA
1MKJ 194 VTNMNEHSSR SHSIFLINVK QENTQTEQKL SGKLYLVDLA GSEKV-----
Quality ********** ***.****** *** . . ** ********** *****
Drosophila 251 EGTVLDEAKN INKSLSALGN VISALADGNK THIPYRDSKL TRILQESLGG
1MKJ 251 -------AKN INKSLSALGN VISALAEGS- TYVPYRDSKM TRILQDSLGG
Quality *** ********** ******.*. * .******. *****.****
Drosophila 301 NARTTIVICC SPASFNESET KSTLDFGRRA KTVKNVVCVN EELTAEEWKR
1MKJ 293 NCRTTIVICC SPSSYNESET KSTLLFGQRA KTIKNTVCVN VELTAEQWKK
Quality * ******** **.*.***** **** **.** **.** **** *****.**.
Drosophila 351 RYEKEKEKNA RL
1MKJ 343 KYEKEKE -- --
Quality .******
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protein expression in order to allow attachment of the photo-switchable linker via
maleimide.
The obtained alignment was then used to model the drosophila kinesin-1
structure using SwissModel (http://swissmodel.expasy.org/), an automated on
line modeling server. The resulting structure shows some additional loops in
the drosophila structure which were missing in the crystal structure (shown
as dashes in the human sequence in table 4.1). To illustrate these loops, the
drosophila protein backbone was drawn beneath the surface with the additional
loops highlighted in red (figure 4.5B). Most of these loops are not near the ATP
binding pocket so that one can be quite confident about the structure of the
ATP pocket. The big flexible loop (in the upper right corner of figure 4.5B)
could reach (and cover) the ATP binding pocket. However this loop has been
predicted to facilitate microtubule binding in a previous simulation study160. That
this loop does not likely interact with the ATP binding pocket was confirmed
by optimizing it using a loop database containing several hundred structures of
known loops. The resulting structure (figure 4.5C) was used as the final protein
structure and was not subjected to further optimization. The distance root mean
square deviation between the backbone atoms (DRMSD) of the final drosophila
kinesin-1 structure and the template (1MKJ) was 1.07 Å, showing a high degree
of structural identity between the two protein structures. The quality of this
structure was confirmed with a subsequent energy minimization and dynamic
calculation (software: TINKER 4.2, force field: amber99) which showed no major
changes in the structure within the modeled timeframe of 10 ps. The nucleotide
was lost in the homology modeling process because SwissModel does not support
ligands. The position of ADP was recovered by alignment of an ADP containing
crystal structure with the modeled structure (figure 4.5D).
Molecular dynamics
The structure of AMPPNP with a linker of approximately the right length to reach
from the nucleotide pocket to the cysteine residue was designed in ChemBio3D
(CambidgeSoft; see figure 4.6A for the structure). The trans-conformation of
this linker was fitted into the nucleotide pocket using ADP as template for the
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AMPPNP moiety. Rotating around single bonds, the linker was twisted until
it reached the cysteine residue. A covalent bond was then formed between the
sulfhydryl group of cysteine and the maleimide moiety of the linker. This structure
was optimized by energy minimization using a force field (MM2) optimized for
AMPPNP
linker
azobenzene
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Figure 4.6: Tether design - Model of an AMPPNP residue tethered to kinesin-1
via a switchable tether. (A) Drawing of the chemical structure of AMPPNP (black)
with a linker (green) containing azobenzene (blue). A maleimide moiety (red) can
be used for specific attachment to a cysteine residue. (B) AMPPNP tethered to
the predicted drosophila kinesin-1 structure (see 4.2) with the tether in trans form.
(C) As (B) but tether in cis-form.
organic molecules rather than whole proteins. Therefore, only the atoms of the
tethered AMPPNP were allowed to move during all simulations using this force
field. While the atoms of the protein were not allowed to move, their steric energy
and their influence on the tethered AMPPNP was still taken into account. To
simulate a light induced switching event, the N−N-bond was rotated by 180˚
followed by another minimization step. The structure containing azobenzene in
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trans-conformation (figure 4.6B) was not under a lot of strain evident by the
possibility to reach the cysteine residue by simply rotating single bonds. In
contrast, when azobenzene was in cis-conformation (figure 4.6C), the tether was a
lot tighter and could only be fitted to the structure by energy minimization.
A
C
B
D
trans before modelling trans after modelling
cis before modelling cis after modelling
Figure 4.7: Molecular dynamics calculations - Structures of the tethered
AMPPNP are shown in trans (A, B) and cis (C, D), before (A, C) and after (B,
D) dynamic calculations. The nucleotide binding pocket is indicated by a magenta
coloring of the protein surface.
The minimized cis– and trans structures were then used as starting points
for molecular dynamics calculations. A time-frame of 4 ps was modeled with a
step interval of 2 fs, target temperature of 300 K and a heating/cooling rate of
4.22 kJ/(atom · s). While the AMPPNP residue connected to the trans tether did
move, it stayed within the nucleotide binding pocket for the whole modeled time
(figure 4.7A and B). In contrast, the tether in cis-conformation was under so much
strain, that it pulled the nucleotide out of kinesin-1’s binding pocket (figure 4.7C
and D).
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Discussion
According to the approach presented here, optical switching of kinesin-1 would be
achieved by tethering AMPPNP to kinesin-1’s binding pocket. The feasibility of
this approach is supported by preliminary experiments and molecular modelling.
These experiments showed that a tether attached to ATP’s 2’ or 3’ hydroxyl
group can still bind kinesin-1 and activate (albeit slow) microtubule gliding.
Furthermore, molecular dynamic simulations indicated that the proposed tether
behaves as desired. This modeling was performed with tight constraints, keeping
the protein rigid and using a force field optimized for organic compounds rather
than proteins. While reality is likely going to be more complex, the simulations
indicate, that the tether in the short, bright state pushes the equilibrium between
bound and unbound AMPPNP towards the unbound state. Therefore, the modified
kinesin-1’s nucleotide pocket should be more available for ATP binding in the
bright state than in the dark state, thus achieving optical switching. Whether
this switching is from a complete on, to a complete off state or a more partial
switching, needs to be tested in real experiments.
The main achievement of the preliminary experiments shown here, is to show
that it is worthwhile to pursue the proposed approach. The required next steps
will be discussed on page 78.
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5.1 Kinesin-1’s behavior at roadblocks
Aspiring towards an improved understanding of the behavior of kinesin-1 at obsta-
cles, it was shown, that single molecules of this motor stop when they encounter
obstacles in their path on a microtubule. In this stopped state, kinesin-1’s dis-
sociation rate is increased roughly fourfold compared to the dissociation rate
during its normal walking cycle. The following model for the mechanism with
which kinesin-1 stops at obstacles was proposed: Kinesin-1’s processivity requires
the rear head to stay bound until the leading head is firmly attached to the next
tubulin dimer12,63,64,70,137,138. The fact that kinesin-1 follows a single protofilament
limits the choice of forward binding to the next tubulin dimer along the same protofil-
ament63,114,138. Therefore, if a large molecule is blocking the next tubulin dimer, the
leading head cannot bind and the rear head cannot detach. This situation effectively
stalls the kinesin-1 molecule until it detaches from the microtubule or a forward binding
site becomes free. Based on this model, it was possible to calculate kinesin-1’s
dissociation rate in the stopped state. This calculated value agreed very well with
a direct measurement, indicating that the model accurately describes kinesin-1’s
behavior at obstacles. Interestingly, in about 50 % of the observed stopping
events, kinesin-1 did not detach at the end of the stopping phase, but overcame
the obstacle and continued to walk. The rate with which kinesin-1 exits the
stopped phase by overcoming obstacles was almost identical to the dissociation
rate measured for stopping events. Therefore, it is highly likely that kinesin-1
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overcomes a roadblock by detaching and then, instead of leaving into solution,
reattaching next to, or behind the obstacle.
Follow-up experiments: A first and relatively easy follow-up to verify the
proposed model describing kinesin-1’s behavior at obstacles could be to measure
the dissociation rate in the stopped state for different obstacle densities. While
it is expected, that run length and dwell time vary depending on the obstacle
density, the resulting dissociation rate should stay the same.
Studying in vivo obstacles: Kinesin-1’s dissociation rate in the stopped state
was probably adapted by evolution to suit it’s tasks in vivo. Therefore, it would
be interesting to measure the dissociation rate for obstacles that, in contrast to
streptavidin, also occur in vivo. Especially interesting in this respect could be the
microtubule associated protein tau. At low density, Seitz et al. 142 showed that
this protein has no effect on kinesin-1’s run-length and dwell time. In contrast,
high concentrations were shown to form patches on the microtubule which cause
kinesin-1 to detach133. These observations are possibly related to Alzheimer’s
disease, where increased intracellular concentrations cause tau to form aggregates
in neurons. Using the methodology presented in chapter 2, it could be measured,
if kinesin-1’s dissociation rate varies depending on the concentration of tau. If this
were the case, it would indicate that single tau molecules do not act as a roadblock
but higher concentrations lead to the formation of aggregates which do form
roadblocks. This effect could indicate, that part of the neurodegenerative effect of
Alzheimer’s disease is caused by an interruption of kinesin-1 based transport in
neurons.
High-resolution experiments: Two new questions that could not be answered
with the results shown here are: (i) ”Does kinesin-1 wait in front of obstacles in a
single- or a double headed bound state?” and (ii) ”How does kinesin-1 manage
to overcome obstacles?” Both questions could be answered using high resolution
optical tweezer experiments to measure the detachment force and particle tracking
to precisely determine the path on the microtubule without external force. For
both experiments, the detection particle should be directly attached to a motor
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head. If kinesin-1 waits in a single headed bound state, the detachment force
should be lowered and the Brownian motion should be increased. Accordingly,
if kinesin-1 overcomes obstacles by dissociation and rebinding, an external force
should prevent rebinding and particle tracking should reveal diffusional movement
along the microtubule.
Other motors: Finally, it would be interesting to measure dissociation rates
at obstacles for other motors of the kinesin family. For example, motors with
low processivity might be less affected by very high cargo densities. Promising
candidates are kinesin-5 and kinesin-14 two motors involved in mitotic spindle
formation161. In comparison it would also be interesting to study kinesin-8, a
very processive motor responsible for length dependent microtubule depolymer-
ization162. In addition to helping to understand how different motors cope with
crowded microtubules in vivo, these experiments could also help to find motor
proteins more suited than kinesin-1 for the transport of microtubules loaded with
extremely high amounts of cargo in nanotechnological applications.
5.2 Refining molecular detection
How kinesin-1’s behavior at roadblocks affects cargo transported by multiple
motors was tested using gliding motility assays. In these assays, microtubules are
propelled by multiple surface-attached kinesin-1 molecules. These experiments
showed that with increasing obstacle density, the speed of gliding microtubules
goes down in a predictable way. The mechanism behind this slow-down is probably
related to the stopping at obstacles observed for single kinesin-1 molecules: Out
of the many kinesin-1 molecules transporting a microtubule, some are likely stalled
by obstacles at all times. These stalled motors are then probably stretched by the
remaining walking molecules, causing an increased ”drag force” that slows down the
gliding microtubule. Interestingly, this decrease in speed was detectable even for
very low obstacle densities. Molecular detection based on this roadblock effect was
demonstrated by measuring the selective slow-down of two distinct microtubule
populations. However, this detection relied on the interactions of small recognition
probes (biotin, rhodamine) with proteins. In order to generalize this method for the
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detection of a wide variety of analytes the use of analyte-specific antigen binding
fragments of antibodies or DNA-aptamers as recognition probes was investigated.
As a first step, it was shown that an analyte (anti-streptavidin antibody) binding
to a recognition probe as large as a FAB (streptavidin) can still be detected.
Motivated by this promising result, a technique was developed to covalently attach
aptamers to microtubules. In a preliminary experiment the density of active
aptamers on microtubules was very low, probably due to degradation of the
aptamers. This degradation could be counteracted by using sterile conditions and
adding EDTA to lower DNAse activity during the conjugation reaction. Also, the
reaction might be more efficient using longer linker molecules, because longer, more
flexible linkers will compensate in part for the slow diffusion and steric hindrance
caused by the relatively large size of the reaction partners (microtubules and
aptamers). Using microtubules coated with aptamers, it should then be possible
to demonstrate the specific detection of a protein out of a complex solution.
This constitutes the first milestone achievement towards developing the detection
method into a usable application.
Integrated detection devices: The fact that the analyte is transported by
gliding microtubules promises easy integration with other miniaturized devices
developed for this biomolecular transport platform, making this detection method
highly promising for future applications. For example, preliminary experiments
(not shown) indicate, that it is possible to run a gliding assay within a microinjec-
tion needle used for single cell injections. With this method, it might be possible
to detect molecules from single cells: The cytosol of single cells can be sucked
into the tip of a microinjection needle (e.g. for single-cell PCR experiments).
Aptamer-coated microtubules would then transport the target analyte out of
the cytosol filled area with a speed that is faster than diffusion. This transport
should constitute a purification step, because aptamers have a higher affinity for
microtubules than other microtubule associated proteins or microtubule based
motors (in the presence of ATP). This purification should help to significantly
improve the detection limit, hopefully into a regime sufficient for the detection
of proteins from single cells. In terms of concentration, the detection limit does
not need to be terribly low, because a single copy of a protein inside a cell with a
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volume of 5 pl (= 5 µm3, the volume of a human dermal fibroblast163) is 0.3 pM,
which is a concentration that can be detected using antibodies164,165. However,
the minimum number of molecules necessary for detection was estimated to be
600 in chapter 3, corresponding to a concentration of 200 pM. While not suitable
for proteins expressed with very low copy numbers, most intracellular proteins
exceed this concentration166,167. This application would constitute a significant
improvement compared to current single-cell PCR methods, because it would
allow the detecion of mRNA and protein expression at the same time from the
same cell.
5.3 Improving spatio-temporal control
As shown in this thesis and in a prototype ”smart dust” biosensor109,110, detection
alone does not require fine control over the kinesin-1-microtubule gliding motility
assay. However, the lack of precise and flexible spatio-temporal control mechanisms
for this motor has seriously hampered the development of more complex appliances
like nano-assembly-lines. Therefore, several approaches for more detailed control
were investigated. Temperature controlled starting and stopping of microtubules
was achieved by attaching biotinylated PNIPAM, a thermoresponsive polymer, to
streptavidin coated microtubules. In the collapsed state of these polymers (at high
temperatures), microtubules were stuck to the surface. At lower temperatures,
when the polymers were swollen, the microtubules were either released into
solution or continued to glide. Together with a method for local heating by light
(currently being developed in the lab30, this method could be used to start and stop
single microtubules. However, as a first step towards this goal, the demonstrated
temperature dependent switching needs to be optimized for a more homogeneous
switching. To achieve this, the relevant parameters, hydrophobicity of the surfaces,
length of the polymer chains and kinesin-1 density need to be varied systematically
to find the optimal settings. Additionally, polymers could be attached directly to
microtubules using amino-reactive chemistry. Such polymers are currently being
synthesized by our collaborators Dirk Kuckling and Wolfgang Birnbaum at the
Universität Paderborn. The main challenge to be overcome is the purification
of the polymer coated microtubules from excess, unreacted polymer. The most
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promising approach for this purification step is centrifuging the microtubules
through a glycerol cushion. For these polymer-coated microtubules, it would also
be interesting to measure the roadblock effect including the dissociation rate of
kinesin-1 in the collapsed and the extended states of the polymer.
An approach to create photo-switchable kinesin-1: Controlling polymer-
coated microtubule gliding on kinesin-1 coated surfaces would be complemented
very well by a method to control single kinesin-1 molecules. This method would not
be limited to the control of motility near a surface, but would allow motility control
in other geometries like a stepping assay. Such control of single kinesin-1 molecules
could be achieved by covalently linking AMPPNP via a photo-switchable linker
to the nucleotide binding pocket. A similar approach was successful in creating
a photo-switchable glutamate receptor31. Based on that approach, a strategy
was devised to create a photo-switchable kinesin-1. Preliminary experiments
have confirmed the feasibility of this approach by showing that an ATP molecule
modified with an extension similar to the proposed linker still binds to kinesin-1’s
nucleotide pocket. Also, a tether containing a photo-switchable azobenzene group
was designed that connects an AMPPNP molecule in kinesin-1’s nucleotide binding
pocket to a nearby loop of the protein. Molecular modeling indicated, that this
linker allows binding of AMPPNP to the nucleotide binding pocket in one photo-
state and pulls the nucleotide out of the pocket upon switching into the other
photo-state. These preliminary results indicate, that the proposed approach for
the design of a photo-switchable kinesin-1 is highly promising and should be
pursued further. The next steps towards creating an optically-switchable kinesin-1
molecule would be:
1. Generating a cys-light drosophila kinesin-1 with a S109C mutation to facili-
tate specific tether attachment
2. Synthesizing the modified AMPPNP. A good starting point is eda-AMPPNP
(e.g. Jena Bioscience, Jena, Germany), which is already modified at the
2’ or 3’ hydroxyl group and allows easy attachment to these groups using
amino-reactive chemistry. The linker used for modelling already accounts
for this modification.
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3. Reacting the mutated kinesin-1 with the modified AMPPNP. The biggest
challenge here is the purification. First, excess unreacted modified-AMPPNP
needs to be removed (using a desalting column). Afterwards, switchable
kinesin-1 could be removed from non switchable kinesin-1 by a modified
affinity purification that makes use of the switching behavior: The modified
kinesin-1 could be sedimented together with microtubules in the dark in the
presence of ATP. Thereby, only motor proteins which are bound tightly to
the microtubules by their tethered AMPPNP would be pulled down. Later,
the same motors could be released by illuminating them with 380 nm light
in the presence of ATP.
5.4 Concluding remarks
Kinesin-1’s temporary stopping at roadblocks seems to be uniquely optimized for
fast cargo transport on highly crowded microtubules: Being stuck in a traffic jam,
it is more efficient to wait when an obstacle is transient and to take a detour (i.e.
detach and reattach), when the obstacle blocks the path for a long time. This is
just one more example showing that natural evolution finds elegant solutions for
almost any kind of problem. Therefore learning from- and using nature’s treasures
is, in the author’s humble opinion, the most promising approach for (nano-)
technological advances. One example where this has been quite successful is the
development of aptamers: First, antibodies were used as they were provided by
nature. Then, when the process nature uses to create antibodies was understood,
it was possible to use bacteria and phages to create custom-made antigen binding
fragments. Finally, this process was separated completely from living organisms
to create chemically synthesized aptamers. This general strategy is also applicable
for molecular motors. At the moment we are still in the process of understanding
how they work and learning to use and control them in first prototype appliances.
However, it is likely just a matter of time — and a lot of hard work — until
we are able to imitate nature’s mastery of the nano-world and design our own
nano-machines.
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Materials and methods
6.1 General
Unless specifically mentioned, all experiments were performed at leas three times
with similar results. If not specifically mentioned otherwise, all chemicals were
purchased from Sigma. All concentrations given are final concentrations. For
example, if a buffer containing 1 mM MgCl2 is mentioned to be supplemented
with 4 mM MgCl2, this means that the final concentration of MgCl2 was 4 mM.
Buffers and solutions
BRB80: 80 mM PIPES/KOH, pH 6.9; 1 mM EGTA, 1 mM MgCl2.
BRB20: 20 mM PIPES/KOH, pH 6.9; 1 mM EGTA, 1 mM MgCl2.
Piranha solution: 175 ml H2SO4 (70 %) + 75 ml H2O2 (30 %). Careful: highly
corrosive, might explode if mixed with organic solvents! Mix by slowly
adding H2O2 to H2SO4. Use protective gear and work under a closed fume
hood!
High pH cushion: 0.1 M HEPES/NaOH, pH 8.6, 1 mM MgCl2, 1 mM EGTA,
60 % (v/v) glycerol.
Labeling buffer: 0.1 M HEPES/NaOH, pH 8.6, 1 mM MgCl2, 1 mM EGTA,
40 % (v/v) glycerol.
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Quenching solution: 2xBRB80 supplemented with 100 mM K-Glutamate and
40 % (v/v) glycerol.
Low pH cushion: BRB80 supplemented with 60 % (v/v) glycerol.
Injection buffer: 50 mM K-Glutamate, 0.5 mM MgCl2, pH ≈ 7.0.
Motor solution: BRB80 supplemented with 2 µg/ml wild-type kinesin-1 (full
length drosophila kinesin-1 expressed in bacteria and purified as previously
described66), 1 mM ATP and 1 % β-mercapto-ethanol
Motility solution: 1 mM ATP, 20 mM D-glucose, 20 µg/ml glucose oxidase,
10 µg/ml catalase, 0.5 % β-mercapto-ethanol, 10 µM taxol in BRB80.
AMPPNP motility solution: Motility solution with 0.1 mM AMPPNP in-
stead of ATP.
PNIPAM solution: AMPPNP motility solution supplemented with 0.1 mM 40
kDa PNIPAM (kindly provided by Wolfgang Birnbaum and Dirk Kuckling,
Universität Paderborn, Germany).
Single molecule motility solution: BRB20 supplemented with 0.1 mg/ml ca-
sein, 1 mM ATP, 2 % β-mercaptoethanol, 40 mM glucose, 40 µg/ml glucose
oxidase, 20 mg/ml catalase, and 2.5 nM truncated, GFP-labeled kinesin-1
constructs (rkin430GFP ), which contained the first 430 amino acids of
kinesin-1 fused to a GFP and a his-tag at the tail domain, cloning and
purification have been described168.
Flow cells
Experiments were performed in 1.5 to 2 mm-wide flow cells self-built from two
glass coverslips (Corning, 22x22 mm2 and 18x18 mm2) glued together by heated
pieces of Nescofilm (Roth, thickness 0.1 mm).
Depending on the requirements of the respective experiment, glass coverslips
were treated either by the easy clean procedure or by silanization as described in
the following sections.
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Easy clean procedure
Glass cleaned by this easy procedure was used for all gliding motility experiments.
Glass coverslips were loaded into polytetrafluoroethylene (teflon) racks, placed
into a glass container and filled with Mucasol (1:20 dilution in deionized water)
such that all coverslips were completely covered. The mucasol covered glass was
sonicated (using Bransonic 2510, Branson) for and rinsed with deionized water
for 2 min. The water was removed from the container using a (for example 1 ml)
pipette tip connected to the vacuum line. Subsequently, the container was filled
with ethanol, again immersing the coverslips completely, sonicated for 10 min,
and rinsed with nanopure water for 2 min in the container. The racks were then
taken out of the container and the coverslips carefully blown dry using nitrogen.
When used under the microscope, these surfaces are mildly hydrophilic. Being
usually void of any fluorescent particles, they are even suited for single-molecule
fluorescence measurements.
Hydrophobic silanized surfaces
Hydrophobic surfaces were used for single molecule stepping assays to strongly
adsorb antibodies (against tubulin) in combination with the possibility to block
the rest of these surfaces against unspecific protein binding by Pluronic F127 (see
below).
Cleaning: Glass coverslips were loaded into Teflon racks, placed into a glass
container and covered with acetone. After preincubation for 30 min at room
temperature, the acetone covered coverslips were sonicated for 20 min. The
acetone was removed by rinsing for 2 min with deionized water. Next, 250 ml of
piranha solution were prepared in a fresh glass box and heated to 60°C. Caution:
Always use a fresh glass box. Otherwise residual acetone from the previous step
might cause an explosion!. The Teflon holder with the coverslips was incubated
in this solution for 60 min at 60ºC. Afterwards, the holder with the coverslips
was moved into a new glass box with nanopure water, incubated for 1 min, rinsed
again with nanopure water for 2 min and incubated for 15 min in 0.1 M KOH.
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After another 1 min and 2 min wash sequence with nanopure water, the coverslips
were blown dry with nitrogen.
Silanization: 125µl diphenyldimethoxysilane were carefully dissolved in 250ml
trichlorethylene in a glass box. The Teflon holder with the cleaned coverslips was
incubated in this solution for 60 min at room temperature, followed by two steps
of sonication for 5 min and for 15 min, both in methanol. Finally, the coverslips
were rinsed for 2 min in nanopure water, transferred into a clean Teflon holder
and stored in a closed glass box.
6.2 Microtubules
Microtubules were polymerized from 5 µl of bovine brain tubulin (4 mg/ml, Cy-
toskeleton Inc.) in BRB80 buffer supplemented with 4 mM MgCl2, 1 mM Mg-GTP,
and 5 % DMSO at 37˚C. After 60 min, the microtubule polymers were stabilized
and diluted 100-fold in BRB80 containing 10 µM taxol at room temperature. Flu-
orescently labeled and biotinylated microtubules were created by mixing labeled
tubulin (rhodamine and fluorescein) with biotinylated and non-labeled tubulin
before microtubule assembly.
Streptavidin coating of microtubules
Streptavidin coating of gliding and surface-immobilized microtubules was per-
formed by washing out unbound microtubules and flowing a streptavidin solution
(10 µM streptavidin (Pierce) or 10 µM fluorescein-labeled streptavidin (Pierce)
in motility buffer, unless stated differently) into the flow cell. Streptavidin was
removed after 10 min of incubation by washing twice with motility solution. The
same procedure was applied for streptavidin and rhodamine antibody coating in
the molecular detection experiment.
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Detection of antibody binding to streptavidin-coated mi-
crotubules
Streptavidin-coated microtubules were prepared as described above. Flowchannels
were then perfused with a solution of 100 nM fluorescein conjugated polyclonal
anti-streptavidin antibody produced in rabbit (Rockland Immunochemicals) and
1 µM biotin (to block a biotin cross-reactivity of the antibody) in motility buffer.
After 10 min this solution was washed out twice with motility buffer and the
microtubule speeds were measured after 5 min temperature equilibration.
Aptamer coated microtubules
Labeling tubulin with SHTH: Labeling was performed similar to the proce-
dure described by Hyman et al. 169 : 60 mg unlabeled tubulin was polymerized for
1h at 37˚C in 10 ml BRB80 supplemented with 3.5 mM MgCl2, 1 mM GTP and
50 % glycerol. Unpolymerized tubulin was removed by centrifugation through
a warm (37˚C) high pH cushion in a Beckman TLA100 ultracentrifuge (Beck-
man Coulter, Fullerton, CA) using a 50.2 Ti rotor at 40000 rpm for 45 min at
37˚C. The supernatant was discarded, the pellet was rinsed twice with- and
resuspended in 1 ml pre-warmed (37˚C) labeling buffer. 50 µl 20 mM SHTH in
DMSO (≈ 2-5 fold molar excess) was added to the microtubule suspension (not
exceeding a total of 5 % DMSO). After 30 min incubation at 37˚C, the labeling
reaction was quenched by adding 1 ml quenching solution (mix well by vortexing).
The quenched solution was layered onto 1.5 ml low pH cushion in two TLA100.3
tubes, followed by 20 min ultracentrifugation (37˚C, 80000 rpm, TLA100.3 rotor,
Beckman TLA100 ultracentrifuge). The supernatant of this centrifugation step
was discarded, the pellet washed twice with pre-warmed (37˚C) BRB80, resus-
pended in 1 ml of ice-cold injection buffer and incubated on ice for 1 h to promote
depolymerization of the labeled microtubules. The remaining microtubules and
aggregates of denatured tubulin were removed by another centrifugation step
(10 min, 2˚C, 80000 rpm, TLA100.3 rotor, Beckman TLA100 ultracentrifuge).
The supernatant from this centrifugation was recovered and 5x BRB80 was added
to a final concentration of 1x BRB80. This solution was supplemented with 4 mM
MgCl2 and 1 mM GTP and incubated at 37˚C for 30 min to promote microtubule
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polymerization. Unpolymerized tubulin was removed by 20 min centrifugation
through low pH cushion (37˚C, 80000 rpm, TLA100.3 rotor, Beckman TLA100
ultracentrifuge). The supernatant was discarded, the pellet was rinsed twice with
pre-warmed (37˚C) injection buffer, resuspended in 1 ml of ice-cold injection
buffer and incubated on ice for 1 h to promote microtubule depolymerization. A
final centrifugation step was used to remove non-depolymerized tubulin (10 min,
2˚C, 80000 rpm, TLA100.3 rotor, Beckman TLA100 ultracentrifuge). The su-
pernatant containing labeled tubulin was aliquoted in 250 µl aliquots, frozen in
liquid nitrogen and stored at -80˚C.
Measuring the labeling ratio: The tubulin concentration was estimated by
measuring the absorption at 280 nm, assuming an extinction coefficient for tubulin
dimers of 115000 M−1c−1m42. Afterwards, the molar concentration of hydrazide
groups was measured by incubating the labeled tubulin for 1 h at 37˚C with
0.5 mM p-nitrobenzaldehyde and measuring the absorbance at 390 nm, assuming
an extinction coefficient of 22000 M−1c−1m. Afterwards, the molar concentration
of hydrazide groups was ivided by the molar concentration of tubulin dimers,
resulting in an average labeling ratio of ≈ 2.
Labeling Aptamers with SFB: Aptamers were ordered (Eurofins MWG
Operon, Ebersberg, Germany) with a 5’-NH and a 3’ fluorescein tag. The -NH
tag was reacted with SFB using the following procedure: Add 0.2 0.2 µl of a 100
mM SFB solution (in DMSO) to 9.8 µl 0.1 mM aptamer solution (in BRB80, pH
8.0) and incubate for 30 min.
Purify modified aptamers using isopropanol precipitation: Add 0.1 volume
of 5 M NaCl and 2 volumes of isopropanol and mix thoroughly. Precipitate at
room temperature for 10 min. Centrifuge for 10 min at 17000 rpm in a Heraeus
BiofugeStratos tabletop centrifuge (Thermo Fisher Scientific, Waltham, MA).
Wash the DNA pellet three times with 100 µl 70 % ethanol supplemented with
1 mM EDTA. Incubate 5 min at room temperature. Remove ethanol and resuspend
in the original volume BRB20.
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Conjugating SFB-aptamers with SHTH-microtubules: Microtubules were
grown from a mixture of 1:3 rhodamine : unlabeled tubulin or 1:3:4 rhodamine :
unlabeled : SHTH tubulin. 5 µl of each of these microtubule populations were
then incubated with 10 µl SFB modified, fluorescein labeled aptamers for 48 h
and applied to a gliding assay. Microtubules were allowed to bind for 10 min.
Afterwards, excess aptamer-microtubule solution was washed out by flowing in
motility solution without microtubules twice.
Microtubules coated with streptavidin and PNIPAM
Microtubules coated with streptavidin were prepared within a gliding assay as
described above. Then, the flow chamber was mounted onto a temperature
stage (see below) and cooled to 20˚C. To stop gliding motility (and avoid losing
microtubules into solution), 20 µl of an AMPPNP motility solution was perfused
into the flow cell. Thereafter, 10 µl PNIPAM solution was perfused into the
channel and incubated for 30 min at 20˚C. The PNIPAM was washed out once
with AMPPNP motility solution, followed by three washes with motility solution.
Now, 4 s time-lapse imaging was started and the temperature of the setup was
varied using the temperature stage.
6.3 In vitro motility assays
Gliding assays
For gliding assays, a casein-containing solution (0.5 mg/ml in BRB80 was perfused
into a flow cell made of easy clean treated coverslips and allowed to adsorb to
the surfaces for 5 min. Next, 50 µl motor solution was perfused into the flow cell
and allowed to adsorb for 5 min. Thereafter, a motility solution containing 10 %
fluorescently labeled, taxol-stabilized microtubules was applied.
Testing Alexa-647 ATP
Because of precipitation problems with Alexa-647 ATP the motility solutions were
prepared with 10 mM phosphate buffer, pH 7.4 instead of 80 mM BRB80/KOH,
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pH 6.9. Two channels with casein and motor solution were prepared as described
for the standard gliding motility assays (see above). However, the motor solution
was not followed directly by motility solution, but by three washes with 20 µl
(≈ three channel volumes) motility solution without ATP. Afterwards, each channel
was washed with motility solution containing 0.2 mM ATP (channel a) or Alexa-
647 ATP (channel b), respectively. The first measurement was then performed
with 2 mM ATP in channel a and 1 mM Alexa-647 ATP in channel b. Channel b
was additionally perfused with a solution containing 2 mM Alexa-647 ATP and
2 mM Alexa-647 ATP + 2 mM ATP.
Temperature control
In order to get highly reproducible gliding speeds and to be able to control and
switch the temperature during experiments with PNIPAM, it was necessary to
tightly control the temperature of the assays. Temperature controlled imaging is
usually done heating the stage and the objective. However this approach is rather
slow, has a lot of problems with thermal defocusing and does not allow to cool
the sample. In order to circumvent these problems, a temperature control stage
based on a Peltier element (Conrad Elektronik Peltier Element 12714, Germany)
was designed. A holder for this element was constructed that fit to our standard
Zeiss microscopy stages (figures 6.1 and 6.2). The holder consists of two parts, a
bottom part (figure 6.2A) holding the Peltier element and a heat sink (Contrinex
CT08/100, Nettetal, Germany; figure 6.2B). The heat sink was fixed to the bottom
part using two M2 screws. Do not tighten these screws too much, to allow thermal
expansion and contraction of the Peltier element. The Peltier was connected
thermally to the heat sink using heat conductive paste (Electrolube, Swadlincote,
Derbyshire, UK).
To improve heat separation, thermal conduction between the lower and the
upper side of the Peltier element needs to be reduced. Therefore, strips of tape
(TimeMed, Burr Ridge, IL) were put between the Peltier and the bottom part of
the holder and between the lower part of the holder and the heat sink (see also
figure 6.1). The Peltier element was powered by a remotely automated laboratory
power supply (figure 6.2c; Elektro Automatik EA-PS 3016-10B, Viersen, Germany).
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Figure 6.1: Photographs
of the temperature stage
- (A, B) Assembled stage, in
isometric view, and top view,
respectively. (C, D) Disas-
sembled stage. (C) Bottom
part, milled from aluminum.
(D) Heat sink with Peltier el-
ement. Blue circles indicate
the position of the tempera-
ture sensor fixed to the peltier
with tape labeled 3M. See fig-
ure 6.2 for detailed construc-
tion plans.
insulating tape
A B
C D
a
b
Table 6.1: List of parts for an automated polarity switch - Part names,
labels in figure 6.2d, Part number and manufacturers of the parts used to construct
an automated polarity switch.
Name Specifications Label Pt. No. Manufacturer
2 pole relay Input: 24 V; output:
10 A, 125 V
rel Type
44.627.024.4000
Finder,
Rüsselsheim,
Germany
2 pole switch 4 A, 240 V sw 621-1592900NXRS Carlingswitch,
Plainville, CT
Diode bridge
rectifier
IV (AV ): 1.5 A; VRRM :
400 V; IFSM : 50 A
dbr W04G-E4 Vishay, Malvern,
PA
Solid state
relay
Input: 5 V; output:
0.6 A, 240 V
ssr G3DZ-2R6PL 5DC Omron, Kyoto,
Japan
Transformer Primary: 230 VAC,
50− 60 Hz; secondary:
24 VAC, 83 mA
tr BV 030-7309.0 S Era Elektrotechnik,
Gültstein,
Germany
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Figure 6.2: Temperature stage allowing fast temperature control for
imaging - (A) Bottom part holding the Peltier element. Milled from aluminum.
(B) Heat sink, fixed on top of the Peltier to dissipate thermal leakage power. Note
the channels for the thermal sensor (a, 1 mm wide, 0.5 mm deep) and the power
cables of the Peltier element (b, 5 mm wide, 3 mm deep). (A, B) Grey indicates
areas that have been milled down. Dotted lines indicate features that cannot be
seen from the side that is shown. Plans are drawn to scale (50 %). All distances
are given in mm. (C) Connection scheme. (c) Automated power supply (d) Circuit
diagram of a polarity switch. see table 6.1 for a list of parts. (e) Peltier element
with temperature sensor (ts). (f) Computer with a DAQboard 2000 I/O card (out
= analog output channels, in = analog in channel). (g) Thermometer.
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Figure 6.3: Peltier calibration
- The difference of the temperature
of the exposed side of the Peltier
to room temperature depending on
the current applied to the Peltier
element. A current of 0-5 A was
applied with positive and negative
voltage resulting in a temperature
curve for heating (red) and cooling
(blue). Both curves were fitted with
a third order polynomial function.
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The temperature of the Peltier element was measured using a thermometer with
analog readout capability (figure 6.2g; Physitemp BAT 10, Clifton, NJ) and a
tissue implantable thermocouple microprobe (figure 6.2ts; Physitemp IT-23, USA).
Both the thermometer and the power supply were connected to the imaging
computer (figure 6.2f) via an analog I/O PCI card (iotech DAQ Board 2000,
Germany). To switch between heating and cooling, an automated polarity switch
was constructed that allowed computer controlled polarity switching of the Peltier
element (see figure 6.2d and table 6.1).
Temperature control was programmed in a journal within the imaging software
(Metamorph, Universal Imaging Corp., Downington, PA). The journal read out
the temperature and calculated the current necessary for the Peltier to reach the
target temperature. In order to be able to calculate the necessary current, the
characteristic current-temperature relation of the Peltier element were measured
(figure 6.3) and fitted with a third-order polynomial function.
I =0 + a · ∆t+ b · ∆t2 + c · ∆t3 (6.1)
leading to:
I =0.1 · ∆t− 0.0009 · ∆t2 + 0.000004 · ∆t3 for heating and (6.2)
I =0.14 · |∆t| − 0.00459 · ∆t2 + 0.00021 · |∆t|3for cooling. (6.3)
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The parameters obtained were then implemented into the journal. Due to thermal
leakage power, the whole stage heats up during operation. This effect was
diminished during cooling of the sample, because the heat sink dissipated heat
from the hot side of the Peltier element. On the other hand, the heat sink increases
heating of the Peltier element as a whole during heating of the sample, because
the cold side of the Peltier element is warmed up towards room temperature. This
somewhat detrimental effect of the heat sink during heating of the sample was
accepted, because it allows to sustain cold temperatures (< 15˚C) for longer
times. In both cases, the power needs to be constantly adapted to compensate
for these effects, especially for temperatures more than 10 K above or below
room temperature. This was done by implementing a fine tuning algorithm into
the temperature control journal: Whenever the temperature gradient was below
0.2 K/s, this algorithm checked whether the actual temperature still was within
0.2 K of the target temperature. If that was not the case, the algorithm adjusts
the temperature the Peltier element is assumed to have at zero power (initially set
to room temperature). That way, the temperature regulation became very robust
not only against thermal leakage, but also against changes of ambient temperature
and inaccuracies of the assumed characteristics of the Peltier element.
As expected, this setup also showed defocusing upon temperature changes.
However, the defocusing turned out to be linear with temperature and was
compensated for by adjusting the z-position of the microscope stage by 0.77 µm
per K temperature difference. While focus compensation was too slow for very
fast temperature switches, the image was back in focus as soon as the temperature
change slowed down, making manual refocusing obsolete in most cases.
Stepping assays
In stepping assays flow channels made of hydrophobic glass (see above) were used.
To immobilize microtubules, channels were incubated with 0.5 µM monoclonal anti-
β-tubulin antibody produced in mouse clone TUB 2.1 in BRB80 for 5 min, followed
by 30− 60 min with 1 % Pluronic F-127 in BRB80, and finally microtubules in
BRB80 for 5 min. Channels were rinsed with BRB20 before addition of the single
molecule motility solution. Single molecule recordings were performed before and
92
6.4 Image acquisition and data analysis
after streptavidin treatment. BRB20 (a low salt buffer) was used for stepping
experiments because in this buffer a 10 times lower kinesin-1 concentration was
sufficient to generate the same number of events as in BRB80. This significantly
reduced the background caused by non-specific binding of kinesin-1 to the surface.
However, the ratio of moving to non-moving kinesin-1 was comparable in BRB80
(tested for non-biotinylated and 1:4 biotinylated microtubules).
6.4 Image acquisition and data analysis
Fluorescence images were obtained using two microscope setups, both based on a
Zeiss Axiovert 200M inverted optical microscope: (i) Gliding assays were observed
by epi-fluorescence using a 40x air objective (Plan-Apochromat NA 0,95, Zeiss)
or a 100x oil immersion objective (Plan-Neofluar NA 1.3, Zeiss). Images were
acquired with an exposure time of 100 ms in timelapse mode (one frame every
1 s for single color and one frame every 3.5 s for dual color recordings) by a back-
illuminated CCD camera (MicroMax 512 BFT, Roper Scientific) in conjunction
with a Metamorph imaging system (Universal Imaging Corp.) Microtubule speeds
were measured by hand, tracing the microtubule paths over a period of 20 s
in the acquired timelapse movies. The fluorescence intensity per micrometer
of fluorescein-streptavidin-coated microtubule was measured by summing up
the intensity counts of the brightest pixels in a 6 pixel wide line-scan along
the microtubule axis, subtracting the average background and dividing by the
microtubule length in micrometer. Each value represents the mean ± s.d. of
8-13 microtubules. (ii) Stepping assays were observed by total internal reflection
fluorescence (TIRF) microscopy using a 100x oil immersion objective (Zeiss
APOCHROMAT NA 1.46) and a mixed gas argon-krypton laser (Innova 70C
Spectra; Coherent). Image acquisition was performed with 100 ms exposure in
streaming mode by an electron-multiplied CCD camera (iXon DV 897, Andor) in
conjunction with a Metamorph imaging system. In the evaluation of the moving
and stopping dwell times (Fig. 3), only events where the motors landed during
acquisition were counted to avoid errors from the accumulation of dead motors.
Single particle tracking was performed using an in-house software based on MatLab
(Mathworks, Natick, MA). The algorithm uses two-dimensional Gaussian fitting
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(least squares method; variable width of Gaussian) of the pixelated intensity
profiles arising from single particles.
The following filters (Chroma Technology, if not stated otherwise) were used for
imaging: TIRF imaging of GFP with laser excitation at 488 nm: exc 488/10, em
660/50, dc 505 LP for single-color detection. Rhodamine with arc-lamp excitation:
exc 535/50, em 610/75, dc 565 LP. Fluorescein with arc-lamp excitation: exc
480/40, em535/50, dc 505/LP. For simultaneous dual color recordings a spectral
beam splitter (W-view A8509, Hamamatsu) was used with laser 488 excitation
and the following filters: exc 488/10 the W-view beamsplitter was equipped with:
em 660/40, em 531/40 (Semrock), dc 590dcxr, and dc Q590dcspxr The signals of
the two color channels were recorded on two different halves of the same CCD
camera chip. To align the dual-color images with respect to each other - and as a
drift control for tracking - multifluorescent TetraSpeck beads (0.2 µm diameter,
Mo Bi Tec) were diluted 200-fold in BRB80 and additionally perfused into the
flow chambers (incubation time of 5 min) before the flow sequence of the stepping
assays described above.
Correcting for photobleaching
Unlike the ratio of integrated moving times to total dwell times shown in section
2.1 the absolute dwell time and run length are affected by photobleaching of the
dye molecules labeling the motor. Therefore, the time until photobleaching was
optimized using DTT as a reducing agent and by reducing the laser power to
1.4 mW. The remaining photobleaching effect that occurred under these conditions
was corrected for as described by Helenius et al. 139 : The characteristic lifetime
until photobleaching of single rkin430GFP molecules (τbl) was measured separately
for each experiment (usually 10− 13 s). To ensure strong binding of the motors
to the microtubules (i.e. making sure that bleaching is the predominant factor
for the disappearance of fluorescent signal), AMPPNP motility solution (using
the same BRB buffer as in the experiment) was flown into a channel after each
experiment. Imaging of this channel was done with the same illumination settings
as in the experiment. The time until bleaching of each individual GFP molecule
was then analyzed in kymographs (figure 6.4A): Because kinesin-1 is a homodimer,
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Figure 6.4: Measuring bleaching times - (A) Example kymograph of AMPPNP
immobilized single kinesin-1 molecules. The intensity profile of one example molecule
shows two-step bleaching. The individual bleaching steps are labeled 1 and 2. (B)
Histogram of times before bleaching with the corresponding exponential fit and the
characteristic bleaching time (n = 278).
each molecule contains two GFP molecules. The bleaching of each individual
GFP molecule could be observed as two intensity steps (figure 6.4A 1 and 2). The
times before bleaching were then plotted as a histogram and fitted by a single
exponential function (figure 6.4B). The characteristic bleaching time from these
measurements was used to calculate the corrected dwell times (τ) as follows: It
was assumed, that the observed dissociation rates (1/τobs) were the sum of the
corrected dissociation rates (1/τ) and the bleaching rates (1/τbl):
1
τobs
=
1
τ
+
1
τbl
(6.4)
and therefore
τ =
τobs · τbl
τbl − τobs
. (6.5)
The respective errors were calculated using Gaussian error propagation (equation
6.13).
In order to correct the run length for bleaching, it was assumed, that each
molecule moves approximately with the average speed (vavg) of all molecules mea-
sured under the same condition. With this assumption, a length (Lbl) equivalent
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to τbl (i.e. the characteristic length a molecule could walk before it bleaches) can
be calculated: Lbl = τbl · vavg. This Lbl can be used analogous to τbl to calculate
the corrected run lengths (replace τ , τbl and τobs with L, Lbl and Lobs, respectively,
in equations 6.5 and 6.13).
Error propagation
All errors are given as ± one standard deviation. When used to calculate derived
values, standard deviations were propagated using gaussian error propagation
(equations 6.6-6.13). Standard deviations for characteristic values determined
by exponential fitting were estimated from the χ2reduced values and the Jacobian
matrices of the respective fits.
σ2f =
n∑
i=1
(
∂f
∂pi
·σpi
)2
where n = the number of parameters pi
and σpi = the respective errors
(6.6)
σ2v̄− =
(
1
τ−
·σL−
)2
+
(
L−
τ 2−
·στ−
)2
(6.7)
σ2v̄+ =
(
1
τ+
·σL+
)2
+
(
L+
τ 2+
·στ+
)2
(6.8)
σ2Pr =
(
1
v̄−
·σv̄+
)2
+
(
v̄+
v̄2−
·σv̄−
)2
(6.9)
σkoff =
1
τ 2−
·στ− (6.10)
σk+ =
1
τ 2+
·στ+ (6.11)
σ2ks =
(
ks
(
ks
τ+ ·L−
τ−(L− − L+)
− 1
τ−
)
στ−
)2
+
(
−ks
(
ks
τ− ·L+
τ+(L− − L+)
− 1
τ+
)
στ+
)2
+
(
−ks
(
ks
τ+
L− − L+
− 1
L− − L+
)
σL−
)2
+
(
ks
(
ks
τ−
L− − L+
− 1
L− − L+
)
σL+
)2
(6.12)
σ2τ =
(
τ
τobs
− τ
2
τobs · τbl
·στobs
)2
+
(
τ 2
τobs · τbl
− τ
τbl
·στbl
)2
(6.13)
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[91] G. Köhler and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of
predefined specificity. Nature, 256(5517):495–7. 13
[92] G. Winter and C. Milstein. 1991. Man-made antibodies. Nature, 349(6307):293–299. 13
[93] H. Gram, L. A. Marconi, C. F. Barbas, 3rd, T. A. Collet, R. A. Lerner, and A. S. Kang.
1992. In vitro selection and affinity maturation of antibodies from a naive combinatorial
immunoglobulin library. Proceedings of the National Academy of Sciences of the United
States of America, 89(8):3576–80. 13
[94] N. R. Gonzales, R. De Pascalis, J. Schlom, and S. V. S. Kashmiri. 2005. Minimizing the
immunogenicity of antibodies for clinical application. Tumour Biol, 26(1):31–43. 13
[95] K. Kruger, P. J. Grabowski, A. J. Zaug, J. Sands, D. E. Gottschling, and T. R. Cech.
1982. Self-splicing rna: autoexcision and autocyclization of the ribosomal rna intervening
sequence of tetrahymena. Cell, 31(1):147–57. 13
[96] C. Guerrier-Takada, K. Gardiner, T. Marsh, N. Pace, and S. Altman. 1983. The rna
moiety of ribonuclease p is the catalytic subunit of the enzyme. Cell, 35(3 Pt 2):849–57.
13
[97] A. D. Ellington and J. W. Szostak. 1990. In vitro selection of rna molecules that bind
specific ligands. Nature, 346(6287):818–22. 13
[98] M. Rimmele. 2003. Nucleic acid aptamers as tools and drugs: recent developments.
ChemBioChem, 4(10):963–71. 14
[99] X. Ye, A. Gorin, R. Frederick, W. Hu, A. Majumdar, W. Xu, G. McLendon, A. Ellington,
and D. J. Patel. 1999. RNA architecture dictates the conformations of a bound peptide.
Chemistry & Biology, 6(9):657–669. 14
[100] T. Nitta and H. Hess. 2005. Dispersion in active transport by kinesin-powered molecular
shuttles. Nano Letters, 5(7):1337–42. 16, 59
[101] G. D. Bachand, S. B. Rivera, A. Carroll-Portillo, H. Hess, and M. Bachand. 2006. Active
capture and transport of virus particles using a biomolecular motor-driven, nanoscale
antibody sandwich assay. Small, 2(3):381–5. 19, 59
[102] A. K. Boal, G. D. Bachand, S. B. Rivera, and B. C. Bunker. 2006. Interactions between
cargo-carrying biomolecular shuttles. Nanotechnology, 17(2):349–354. 16, 23
[103] T. Nitta, A. Tanahashi, M. Hirano, and H. Hess. 2006. Simulating molecular shuttle
movements: towards computer-aided design of nanoscale transport systems. Lab on a
Chip, 6(7):881–5. 59
104
REFERENCES
[104] S. Ramachandran, K.-H. Ernst, G. D. Bachand, V. Vogel, and H. Hess. 2006. Selective
loading of kinesin-powered molecular shuttles with protein cargo and its application to
biosensing. Small, 2(3):330–4. 16, 23
[105] R. K. Doot, H. Hess, and V. Vogel. 2007. Engineered networks of oriented microtubule
filaments for directed cargo transport. Soft Matter, 3(3):349–356. 23, 35
[106] A. Agarwal, P. Katira, and H. Hess. 2009. Millisecond curing time of a molecular adhesive
causes velocity-dependent cargo-loading of molecular shuttles. Nano Letters, 9(3):1170–5.
16, 23, 59
[107] L. Ionov, M. Stamm, and S. Diez. 2005. Size sorting of protein assemblies using polymeric
gradient surfaces. Nano Letters, 5(10):1910–1914. 16, 35
[108] T. Korten and S. Diez. 2008. Setting up roadblocks for kinesin-1: mechanism for the
selective speed control of cargo carrying microtubules. Lab on a Chip, 8(9):1441–7. 16, 23,
39
[109] G. D. Bachand, H. Hess, B. Ratna, P. Satir, and V. Vogel. 2009. ”smart dust” biosensors
powered by biomolecular motors. Lab on a Chip, 9(12):1661–6. 21, 57, 77
[110] T. Fischer, A. Agarwal, and H. Hess. 2009. A smart dust biosensor powered by kinesin
motors. Nature Nanotechnology, 4(3):162–6. 16, 20, 21, 23, 57, 59, 77
[111] B. A. Katz. 1997. Binding of biotin to streptavidin stabilizes intersubunit salt bridges
between asp61 and his87 at low pH. Journal of Molecular Biology, 274(5):776–800. 16
[112] T. Shimoboji, Z. L. Ding, P. S. Stayton, and A. S. Hoffman. 2002. Photoswitching
of ligand association with a photoresponsive polymer-protein conjugate. Bioconjugate
Chemistry, 13(5):915–919. 16, 23
[113] H. Hess, J. Clemmens, C. Brunner, R. Doot, S. Luna, K.-H. Ernst, and V. Vogel. 2005.
Molecular self-assembly of ”nanowires”and ”nanospools” using active transport. Nano
Letters, 5(4):629–33. 19, 59
[114] B. Nitzsche, F. Ruhnow, and S. Diez. 2008. Quantum-dot-assisted characterization of
microtubule rotations during cargo transport. Nature Nanotechnology, 3(9):552–6. 16, 23,
73
[115] N. M. Green. 1990. Avidin and streptavidin. Methods In Enzymology, 184:51–67. 16
[116] F. Rusmini, Z. Zhong, and J. Feijen. 2007. Protein immobilization strategies for protein
biochips. Biomacromolecules, 8:1775–1789. 17
105
REFERENCES
[117] D. J. Brooks, J. R. Fresco, A. M. Lesk, and M. Singh. 2002. Evolution of amino acid
frequencies in proteins over deep time: Inferred order of introduction of amino acids into
the genetic code. Molecular Biology and Evolution, 19(10):1645–1655. 17
[118] K. K. Phelps and R. A. Walker. 2000. Nem tubulin inhibits microtubule minus end
assembly by a reversible capping mechanism. Biochemistry, 39(14):3877–85. 18
[119] S. Diez, C. Reuther, C. Dinu, R. Seidel, M. Mertig, W. Pompe, and J. Howard. 2003.
Stretching and transporting DNA molecules using motor proteins. Nano Letters, 3(9):
1251–1254. 19
[120] R. Tucker, P. Katira, and H. Hess. 2008. Herding nanotransporters: localized activation
via release and sequestration of control molecules. Nano Letters, 8(1):221–6. 20, 21, 63
[121] H. Hess, J. Clemmens, C. Matzke, G. Bachand, B. Bunker, and V. Vogel. 2002. Ratchet
patterns sort molecular shuttles. Applied Physics A: Materials Science & Processing, 75
(2):309–313. 19
[122] K. J. Bohm, J. Beeg, G. M. zu Horste, R. Stracke, and E. Unger. 2005. Kinesin-
driven sorting machine on large-scale microtubule arrays. Ieee Transactions On Advanced
Packaging, 28(4):571–576. 23, 35
[123] J. Howard, A. J. Hudspeth, and R. D. Vale. 1989. Movement of microtubules by single
kinesin molecules. Nature, 342(6246):154–8. 23, 35
[124] W. C. W. Chan, D. J. Maxwell, X. Gao, R. E. Bailey, M. Han, and S. Nie. 2002.
Luminescent quantum dots for multiplexed biological detection and imaging. Current
Opinion in Biotechnology, 13(1):40–46. 26
[125] C. Leduc, F. Ruhnow, J. Howard, and S. Diez. 2007. Detection of fractional steps in cargo
movement by the collective operation of kinesin-1 motors. Proceedings of the National
Academy of Sciences of the United States of America, 104(26):10847–10852. 26, 35
[126] R. E. Thompson, D. R. Larson, and W. W. Webb. 2002. Precise nanometer localization
analysis for individual fluorescent probes. Biophysical Journal, 82(5):2775–83. 28
[127] K. S. Thorn, J. A. Ubersax, and R. D. Vale. 2000. Engineering the processive run length
of the kinesin motor. Journal of Cell Biology, 151(5):1093–100. 33, 40, 44
[128] M. Vershinin, B. C. Carter, D. S. Razafsky, S. J. King, and S. P. Gross. 2007. Multiple-
motor based transport and its regulation by tau. Proceedings of the National Academy of
Sciences of the United States of America, 104(1):87–92. 35
[129] D. St Johnston. 2008. Counting motors by force. Cell, 135(6):1000–1. 35
106
REFERENCES
[130] S. J. Kron, Y. Y. Toyoshima, T. Q. P. Uyeda, and J. A. Spudich. 1991. Assays for actin
sliding movement over myosin-coated surfaces. Methods In Enzymology, 196:399–416. 35
[131] M. Mazumdar, A. Mikami, M. A. Gee, and R. B. Vallee. 1996. In vitro motility from
recombinant dynein heavy chain. Proceedings Of The National Academy Of Sciences Of
The United States Of America, 93(13):6552–6556. 35
[132] I. M. Crevel, M. Nyitrai, M. C. Alonso, S. Weiss, M. A. Geeves, and R. A. Cross. 2004.
What kinesin does at roadblocks: the coordination mechanism for molecular walking.
EMBO Journal, 23(1):23–32. 39, 40
[133] R. Dixit, J. L. Ross, Y. E. Goldman, and E. L. F. Holzbaur. 2008. Differential regulation
of dynein and kinesin motor proteins by tau. Science, 319(5866):1086–1089. 46, 74
[134] I. A. Telley, P. Bieling, and T. Surrey. 2009. Obstacles on the microtubule reduce the
processivity of kinesin-1 in a minimal in vitro system and in cell extract. Biophysical
Journal, 96(8):3341–3353. 39, 40, 47
[135] A. Seitz and T. Surrey. 2006. Processive movement of single kinesins on crowded
microtubules visualized using quantum dots. EMBO Journal, 25(2):267–277. 39, 47
[136] Y. Vugmeyster, E. Berliner, and J. Gelles. 1998. Release of isolated single kinesin molecules
from microtubules. Biochemistry, 37(2):747–757. 40
[137] C. L. Asbury, A. N. Fehr, and S. M. Block. 2003. Kinesin moves by an asymmetric
hand-over-hand mechanism. Science, 302(5653):2130–2134. 40, 73
[138] S. Ray, E. Meyhofer, R. A. Milligan, and J. Howard. 1993. Kinesin follows the microtubules
protofilament axis. Journal of Cell Biology, 121(5):1083–1093. 40, 73
[139] J. Helenius, G. Brouhard, Y. Kalaidzidis, S. Diez, and J. Howard. 2006. The depolymerizing
kinesin mcak uses lattice diffusion to rapidly target microtubule ends. Nature, 441(7089):
115–119. 45, 94
[140] G. Fink, L. Hajdo, K. J. Skowronek, C. Reuther, A. A. Kasprzak, and S. Diez. 2009. The
mitotic kinesin-14 ncd drives directional microtubule-microtubule sliding. Nature Cell
Biology, 11(6):717–23. 45
[141] B. H. Kwok, L. C. Kapitein, J. H. Kim, E. J. G. Peterman, C. F. Schmidt, and T. M.
Kapoor. 2006. Allosteric inhibition of kinesin-5 modulates its processive directional
motility. Nature Chemical Biology, 2(9):480. 45
[142] A. Seitz, H. Kojima, K. Oiwa, E. M. Mandelkow, Y. H. Song, and E. Mandelkow. 2002.
Single-molecule investigation of the interference between kinesin, tau and map2c. EMBO
Journal, 21(18):4896–4905. 46, 74
107
REFERENCES
[143] M. Ackmann, H. Wiech, and E. Mandelkow. 2000. Nonsaturable binding indicates
clustering of tau on the microtubule surface in a paired helical filament-like conformation.
Journal of Biological Chemistry, 275(39):30335–43. 46
[144] S. Konzack, E. Thies, A. Marx, E.-M. Mandelkow, and E. Mandelkow. 2007. Swimming
against the tide: mobility of the microtubule-associated protein tau in neurons. Journal
of Neuroscience, 27(37):9916–27. 46
[145] T. W. Wiegand, P. B. Williams, S. C. Dreskin, M. H. Jouvin, J. P. Kinet, and D. Tasset.
1996. High-affinity oligonucleotide ligands to human ige inhibit binding to fc epsilon
receptor i. Journal of Immunology, 157(1):221–230. 54, 55
[146] J. Peloquin, Y. Komarova, and G. Borisy. 2005. Conjugation of fluorophores to tubulin.
Nature Methods, 2(4):299–303. 56
[147] M. Hirabayashi, S. Taira, S. Kobayashi, K. Konishi, K. Katoh, Y. Hiratsuka, M. Kodaka,
T. Q. P. Uyeda, N. Yumoto, and T. Kubo. 2006. Malachite green-conjugated microtubules
as mobile bioprobes selective for malachite green aptamers with capturing/releasing ability.
Biotechnology and Bioengineering, 94(3):473–480. 57
[148] R. Martinez-Neira, M. Kekic, D. Nicolau, and C. G. dos Remedios. 2005. A novel biosensor
for mercuric ions based on motor proteins. Biosensors & Bioelectronics, 20(7):1428–1432.
57
[149] R. J. Chen, S. Bangsaruntip, K. A. Drouvalakis, N. Wong Shi Kam, M. Shim, Y. Li,
W. Kim, P. J. Utz, and H. Dai. 2003. Noncovalent functionalization of carbon nanotubes
for highly specific electronic biosensors. Proceedings of the National Academy of Sciences,
100(9):4984–4989. 58
[150] F. Patolsky, G. F. Zheng, and C. M. Lieber. 2006. Fabrication of silicon nanowire devices
for ultrasensitive, label-free, real-time detection of biological and chemical species. Nature
Protocols, 1(4):1711–1724. 58
[151] G. H. Wu, R. H. Datar, K. M. Hansen, T. Thundat, R. J. Cote, and A. Majumdar. 2001.
Bioassay of prostate-specific antigen (psa) using microcantilevers. Nature Biotechnology,
19(9):856–860. 58
[152] C. Campagnolo, K. J. Meyers, T. Ryan, R. C. Atkinson, Y. T. Chen, M. J. Scanlan,
G. Ritter, L. J. Old, and C. A. Batt. 2004. Real-time, label-free monitorine, of tumor
antigen and serum antibody interactions. Journal of Biochemical and Biophysical Methods,
61(3):283–298. 58
[153] L. L. Jia, S. G. Moorjani, T. N. Jackson, and W. O. Hancock. 2004. Microscale transport
and sorting by kinesin molecular motors. Biomedical Microdevices, 6(1):67–74. 58
108
REFERENCES
[154] Y.-M. Huang, M. Uppalapati, W. O. Hancock, and T. N. Jackson. 2007. Microtubule trans-
port, concentration and alignment in enclosed microfluidic channels. Biomed Microdevices,
9(2):175–84. 58
[155] H. Hess and V. Vogel. 2001. Molecular shuttles based on motor proteins: active transport
in synthetic environments. Journal of Biotechnology, 82(1):67–85. 59
[156] O. Pieroni, A. Fissi, N. Angelini, and F. Lenci. 2001. Photoresponsive polypeptides.
Accounts of Chemical Research, 34(1):9–17. 64
[157] L. Guerrero, O. S. Smart, G. A. Woolley, and R. K. Allemann. 2005. Photocontrol of
dna binding specificity of a miniature engrailed homeodomain. Journal of the American
Chemical Society, 127(44):15624–9. 64, 65
[158] S. Muramatsu, K. Kinbara, H. Taguchi, N. Ishii, and T. Aida. 2006. Semibiological
molecular machine with an implemented ”and” logic gate for regulation of protein folding.
Journal of the American Chemical Society, 128(11):3764–9. 64, 65
[159] C. V. Sindelar, M. J. Budny, S. Rice, N. Naber, R. Fletterick, and R. Cooke. 2002. Two
conformations in the human kinesin power stroke defined by x-ray crystallography and
epr spectroscopy. Nature Structural Biology, 9(11):844–8. 67, 68
[160] W. Wriggers and K. Schulten. 1998. Nucleotide-dependent movements of the kinesin
motor domain predicted by simulated annealing. Biophysical Journal, 75(2):646–661. 69
[161] D. J. Sharp, G. C. Rogers, and J. M. Scholey. 2000. Microtubule motors in mitosis.
Nature, 407(6800):41–7. 75
[162] V. Varga, J. Helenius, K. Tanaka, A. A. Hyman, T. U. Tanaka, and J. Howard. 2006.
Yeast kinesin-8 depolymerizes microtubules in a length-dependent manner. Nature Cell
Biology, 8(9):957–62. 75
[163] X. Wang, T. C. Hua, and B. lin Liu. 2007. A primary study on the water osmotic
characteristics of fibroblasts employed in tissue engineered dermal replacement. Cryobiology,
55(3):349. 77
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